4. REFERENCES
1.Schafer, W., et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn, 2002. 21: 261.
https://pubmed.ncbi.nlm.nih.gov/11948720
2.Abrams, P., et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn, 2009. 28: 287.
https://pubmed.ncbi.nlm.nih.gov/19350662
3.Abrams, P., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 167.
https://pubmed.ncbi.nlm.nih.gov/11857671
4.Groen, J., et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol, 2016. 69: 324.
https://pubmed.ncbi.nlm.nih.gov/26304502
5.Nosseir, M., et al. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn, 2007. 26: 228.
https://pubmed.ncbi.nlm.nih.gov/16998859
6.Panicker, J.N., et al. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol, 2015. 14: 720.
https://pubmed.ncbi.nlm.nih.gov/26067125
7.Phillips, B. Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. 1998.
https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
8.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049.
https://pubmed.ncbi.nlm.nih.gov/18467413
9.Townsend, N., et al. Cardiovascular disease in Europe--epidemiological update 2015. Eur Heart J, 2015. 36: 2696.
https://pubmed.ncbi.nlm.nih.gov/26306399
10.Tibaek, S., et al. Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn, 2008. 27: 763.
https://pubmed.ncbi.nlm.nih.gov/18551565
11.Marinkovic, S.P., et al. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol, 2001. 165: 359.
https://pubmed.ncbi.nlm.nih.gov/11176374
12.Rotar, M., et al. Stroke patients who regain urinary continence in the first week after acute first-ever stroke have better prognosis than patients with persistent lower urinary tract dysfunction. Neurourol Urodyn, 2011. 30: 1315.
https://pubmed.ncbi.nlm.nih.gov/21488096
13.Lobo, A., et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology, 2000. 54: S4.
https://pubmed.ncbi.nlm.nih.gov/10854354
14.Na, H.R., et al. Urinary incontinence in Alzheimer’s disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily Living. Asia Pac Psychiatry, 2015. 7: 113.
https://pubmed.ncbi.nlm.nih.gov/23857871
15.Grant, R.L., et al. First diagnosis and management of incontinence in older people with and without dementia in primary care: a cohort study using The Health Improvement Network primary care database. PLoS Med, 2013. 10: e1001505.
https://pubmed.ncbi.nlm.nih.gov/24015113
16.Pringsheim, T., et al. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord, 2014. 29: 1583.
https://pubmed.ncbi.nlm.nih.gov/24976103
17.Picillo, M., et al. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson’s disease. European Journal of Neurology, 2017. 24: 788.
https://pubmed.ncbi.nlm.nih.gov/28425642
18.Li, F.F., et al. Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson’s disease: A systematic review and meta-analysis. Front Aging Neurosci, 2022. 14: 977572.
https://pubmed.ncbi.nlm.nih.gov/36172485
19.Papatsoris, A.G., et al. Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn, 2008. 27: 22.
https://pubmed.ncbi.nlm.nih.gov/17563111
20.Kim, M., et al. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease. Parkinsonism Relat Disord, 2015. 21: 205.
https://pubmed.ncbi.nlm.nih.gov/25534084
21.Sakakibara, R., et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn, 2016. 35: 551.
https://pubmed.ncbi.nlm.nih.gov/25810035
22.Yamamoto, T., et al. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. J Neurol Sci, 2017. 381: 230.
https://pubmed.ncbi.nlm.nih.gov/28991688
23.Dolecek, T.A., et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol, 2012. 14 Suppl 5: v1.
https://pubmed.ncbi.nlm.nih.gov/23095881
24.Maurice-Williams, R.S. Micturition symptoms in frontal tumours. J Neurol Neurosurg Psychiatry, 1974. 37: 431.
https://pubmed.ncbi.nlm.nih.gov/4365244
25.Christensen, D., et al. Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol, 2014. 56: 59.
https://pubmed.ncbi.nlm.nih.gov/24117446
26.Samijn, B., et al. Lower urinary tract symptoms and urodynamic findings in children and adults with cerebral palsy: A systematic review. Neurourol Urodyn, 2017. 36: 541.
https://pubmed.ncbi.nlm.nih.gov/26894322
27.Ryan, J.M., et al. Prevalence and incidence of chronic conditions among adults with cerebral palsy: A systematic review and meta-analysis. Dev Med Child Neurol, 2023. 65: 1174.
https://pubmed.ncbi.nlm.nih.gov/36807150
28.Tagliaferri, F., et al. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien), 2006. 148: 255.
https://pubmed.ncbi.nlm.nih.gov/16311842
29.Kulakli, F., et al. Relationship between urinary dysfunction and clinical factors in patients with traumatic brain injury. Brain Inj, 2014. 28: 323.
https://pubmed.ncbi.nlm.nih.gov/24377376
30.Aruga, S., et al. Effect of cerebrospinal fluid shunt surgery on lower urinary tract dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn, 2018. 37: 1053.
https://pubmed.ncbi.nlm.nih.gov/28892272
31.Singh, A., et al. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol, 2014. 6: 309.
https://pubmed.ncbi.nlm.nih.gov/25278785
32.Weld, K.J., et al. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology, 2000. 55: 490.
https://pubmed.ncbi.nlm.nih.gov/10736489
33.Kondo, A., et al. Neural tube defects: prevalence, etiology and prevention. Int J Urol, 2009. 16: 49.
https://pubmed.ncbi.nlm.nih.gov/19120526
34.Sawin, K.J., et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr, 2015. 166: 444.
https://pubmed.ncbi.nlm.nih.gov/25444012
35.Wiener, J.S., et al. Bladder Management and Continence Outcomes in Adults with Spina Bifida: Results from the National Spina Bifida Patient Registry, 2009 to 2015. J Urol, 2018. 200: 187.
https://pubmed.ncbi.nlm.nih.gov/29588216
36.Peyronnet, B., et al. Comparison of neurogenic lower urinary tract dysfunctions in open versus closed spinal dysraphism: A prospective cross-sectional study of 318 patients. Neurourol Urodyn, 2018. 37: 2818.
https://pubmed.ncbi.nlm.nih.gov/30070396
37.Joussain, C., et al. Urological dysfunction in patients with hereditary spastic paraplegia. Neurourology and Urodynamics, 2019. 38: 1081.
https://pubmed.ncbi.nlm.nih.gov/30848841
38.Bartolin, Z., et al. Relationship between clinical data and urodynamic findings in patients with lumbar intervertebral disk protrusion. Urol Res, 2002. 30: 219.
https://pubmed.ncbi.nlm.nih.gov/12202938
39.Baker, M., et al. Urogenital symptoms in women with Tarlov cysts. J Obstet Gynaecol Res, 2018. 44: 1817.
https://pubmed.ncbi.nlm.nih.gov/29974579
40.Lange, M.M., et al. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol, 2011. 8: 51.
https://pubmed.ncbi.nlm.nih.gov/21135876
41.Federation, I.D., IDF Diabetes Atlas, 6th edn. 2013, International Diabetes Federation: Brussels, Belgium.
42.Yuan, Z., et al. Diabetic cystopathy: A review. J Diabetes, 2015. 7: 442.
https://pubmed.ncbi.nlm.nih.gov/25619174
43.Tateno, F., et al. Lower Urinary Tract Symptoms in Myasthenia Gravis. Case Rep Neurol, 2021. 13: 490.
https://pubmed.ncbi.nlm.nih.gov/34413752
44.Pugliatti, M., et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol, 2006. 13: 700.
https://pubmed.ncbi.nlm.nih.gov/16834700
45.de Seze, M., et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler, 2007. 13: 915.
https://pubmed.ncbi.nlm.nih.gov/17881401
46.Al Dandan, H.B., et al. Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. Int J MS Care, 2020. 22: 91.
https://pubmed.ncbi.nlm.nih.gov/32410904
47.Gajewski, J.B., et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn, 2018. 37: 1152.
https://pubmed.ncbi.nlm.nih.gov/29149505
48.Liao, L. A new comprehensive classification system for both lower and upper urinary tract dysfunction in patients with neurogenic bladder. Urol Int, 2015. 94: 244.
https://pubmed.ncbi.nlm.nih.gov/25115367
49.Garcia Fadrique, G., et al. Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity. Urol Int, 2020. 104: 273.
https://pubmed.ncbi.nlm.nih.gov/31461727
50.Ahlberg, J., et al. Neurological signs are common in patients with urodynamically verified “idiopathic” bladder overactivity. Neurourol Urodyn, 2002. 21: 65.
https://pubmed.ncbi.nlm.nih.gov/11835426
51.Borau, A., et al. A systematic review of the diagnosis and treatment of patients with neurogenic hyperactivity of the detrusor muscle. Actas Urol Esp (Engl Ed), 2018. 42: 5.
https://pubmed.ncbi.nlm.nih.gov/28413135
52.Musco, S., et al. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review. Neurourol Urodyn, 2018. 37: 1522.
https://pubmed.ncbi.nlm.nih.gov/29392753
53.Farrelly, E., et al. The Stockholm Spinal Cord Uro Study: 3. Urodynamic characteristics in a regional prevalence group of persons with spinal cord injury and indications for improved follow-up. Scand J Urol, 2021. 55: 412.
https://pubmed.ncbi.nlm.nih.gov/34279177
54.Bors, E., et al. History and physical examination in neurological urology. J Urol, 1960. 83: 759.
https://pubmed.ncbi.nlm.nih.gov/13802958
55.Cameron, A.P., et al. The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder. J Urol, 2015. 194: 1336.
https://pubmed.ncbi.nlm.nih.gov/25956470
56.Vodusek, D.B. Lower urinary tract and sexual dysfunction in neurological patients. Eur Neurol, 2014. 72: 109.
https://pubmed.ncbi.nlm.nih.gov/24993182
57.Linsenmeyer, T.A., et al. Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J Spinal Cord Med, 2003. 26: 352.
https://pubmed.ncbi.nlm.nih.gov/14992336
58.Massa, L.M., et al. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. J Spinal Cord Med, 2009. 32: 568.
https://pubmed.ncbi.nlm.nih.gov/20025153
59.Konstantinidis, C., et al. Optimal bladder diary duration for patients with suprapontine neurogenic lower urinary tract dysfunction. Int Braz J Urol, 2016. 42: 766.
https://pubmed.ncbi.nlm.nih.gov/27564288
60.Henze, T. Managing specific symptoms in people with multiple sclerosis. Int MS J, 2005. 12: 60.
https://pubmed.ncbi.nlm.nih.gov/16417816
61.Myers, J.B., et al. Patient Reported Bladder Related Symptoms and Quality of Life after Spinal Cord Injury with Different Bladder Management Strategies. J Urol, 2019. 202: 574.
https://pubmed.ncbi.nlm.nih.gov/30958741
62.Moghalu, O., et al. Psychosocial aspects of health-related quality of life and the association with patient-reported bladder symptoms and satisfaction after spinal cord injury. Spinal Cord, 2021. 59: 987.
https://pubmed.ncbi.nlm.nih.gov/33495582
63.Khalaf, K.M., et al. The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosis. Neurourol Urodyn, 2016. 35: 48.
https://pubmed.ncbi.nlm.nih.gov/25327401
64.Szymanski, K.M., et al. All Incontinence is Not Created Equal: Impact of Urinary and Fecal Incontinence on Quality of Life in Adults with Spina Bifida. Journal of Urology, 2017. 197: 885.
https://pubmed.ncbi.nlm.nih.gov/28131501
65.Pannek, J., et al. Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology, 2009. 74: 263.
https://pubmed.ncbi.nlm.nih.gov/19428089
66.Bonniaud, V., et al. Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference. J Clin Epidemiol, 2008. 61: 505.
https://pubmed.ncbi.nlm.nih.gov/18394545
67.Bonniaud, V., et al. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol, 2008. 180: 2592.
https://pubmed.ncbi.nlm.nih.gov/18950816
68.Best, K.L., et al. Identifying and classifying quality of life tools for neurogenic bladder function after spinal cord injury: A systematic review. J Spinal Cord Med, 2017. 40: 505.
https://pubmed.ncbi.nlm.nih.gov/27734771
69.Welk, B., et al. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction. Neurourol Urodyn, 2018. 37: 2810.
https://pubmed.ncbi.nlm.nih.gov/30168626
70.Welk, B., et al. The creation and validation of a short form of the Neurogenic Bladder Symptom Score. Neurourol Urodyn, 2020. 39: 1162.
https://pubmed.ncbi.nlm.nih.gov/32196732
71.Pariser, J.J., et al. Reliability and Validity of the Neurogenic Bladder Symptom Score in Adults with Cerebral Palsy. Urology, 2019. 128: 107.
https://pubmed.ncbi.nlm.nih.gov/30890419
72.Gulick, E.E. Bowel management related quality of life in people with multiple sclerosis: psychometric evaluation of the QoL-BM measure. Int J Nurs Stud, 2011. 48: 1066.
https://pubmed.ncbi.nlm.nih.gov/21377677
73.Turmel, N., et al. Lower urinary tract symptoms treatment constraints assessment (LUTS-TCA): a new tool for a global evaluation of neurogenic bladder treatments. World J Urol, 2019. 37: 1917.
https://pubmed.ncbi.nlm.nih.gov/30511213
74.Tractenberg, R.E., et al. Clinical Profiles and Symptom Burden Estimates to Support Decision-Making Using the Urinary Symptom Questionnaire for People with Neurogenic Bladder (USQNB) using Intermittent Catheters. PM R, 2021. 13: 229.
https://pubmed.ncbi.nlm.nih.gov/32860333
75.Foley, F.W., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample. Mult Scler, 2013. 19: 1197.
https://pubmed.ncbi.nlm.nih.gov/23369892
76.Sanders, A.S., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Sexuality and Disability, 2000. 18: 3.
77.‘t Hoen, L.A., et al. A Quality Assessment of Patient-Reported Outcome Measures for Sexual Function in Neurologic Patients Using the Consensus-based Standards for the Selection of Health Measurement Instruments Checklist: A Systematic Review. Eur Urol Focus, 2017. 3: 444.
https://pubmed.ncbi.nlm.nih.gov/28753768
78.Tsang, B., et al. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder. Neurourol Urodyn, 2016. 35: 354.
https://pubmed.ncbi.nlm.nih.gov/25620137
79.Schurch, B., et al. Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence. Arch Phys Med Rehabil, 2007. 88: 646.
https://pubmed.ncbi.nlm.nih.gov/17466735
80.Patel, D.P., et al. Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Neurourol Urodyn, 2016. 35: 8.
https://pubmed.ncbi.nlm.nih.gov/25327455
81.Hollingworth, W., et al. Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Qual Life Res, 2010. 19: 323.
https://pubmed.ncbi.nlm.nih.gov/20094804
82.Cella, D.F., et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology, 1996. 47: 129.
https://pubmed.ncbi.nlm.nih.gov/8710066
83.Wesson, J.M., et al. The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire. Mult Scler, 2009. 15: 1239.
https://pubmed.ncbi.nlm.nih.gov/19737850
84.Gold, S.M., et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler, 2001. 7: 119.
https://pubmed.ncbi.nlm.nih.gov/11424632
85.Goodin, D.S. A questionnaire to assess neurological impairment in multiple sclerosis. Mult Scler, 1998. 4: 444.
https://pubmed.ncbi.nlm.nih.gov/9839306
86.Marrie, R.A., et al. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler, 2003. 9: 621.
https://pubmed.ncbi.nlm.nih.gov/14664477
87.Vickrey, B.G., et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res, 1995. 4: 187.
https://pubmed.ncbi.nlm.nih.gov/7613530
88.Honan, C.A., et al. The multiple sclerosis work difficulties questionnaire (MSWDQ): development of a shortened scale. Disabil Rehabil, 2014. 36: 635.
https://pubmed.ncbi.nlm.nih.gov/23786346
89.Bonniaud, V., et al. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire. Arch Phys Med Rehabil, 2004. 85: 1317.
https://pubmed.ncbi.nlm.nih.gov/15295759
90.Franceschini, M., et al. Follow-up in persons with traumatic spinal cord injury: questionnaire reliability. Eura Medicophys, 2006. 42: 211.
https://pubmed.ncbi.nlm.nih.gov/17039217
91.Noreau, L., et al. Development and assessment of a community follow-up questionnaire for the Rick Hansen spinal cord injury registry. Arch Phys Med Rehabil, 2013. 94: 1753.
https://pubmed.ncbi.nlm.nih.gov/23529142
92.Husmann, D.A. Mortality following augmentation cystoplasty: A transitional urologist’s viewpoint. J Pediatr Urol, 2017. 13: 358.
https://pubmed.ncbi.nlm.nih.gov/28645552
93.Yang, C.C., et al. Bladder management in women with neurologic disabilities. Phys Med Rehabil Clin N Am, 2001. 12: 91.
https://pubmed.ncbi.nlm.nih.gov/11853041
94.Podnar, S., et al. Protocol for clinical neurophysiologic examination of the pelvic floor. Neurourol Urodyn, 2001. 20: 669.
https://pubmed.ncbi.nlm.nih.gov/11746548
95.Harrison, S., et al. Urinary incontinence in neurological disease: assessment and management. NICE Clinical Guideline 2012. [CG148].
https://www.nice.org.uk/guidance/cg148
96.Krassioukov, A., et al. International standards to document remaining autonomic function after spinal cord injury. J Spinal Cord Med, 2012. 35: 201.
https://pubmed.ncbi.nlm.nih.gov/22925746
97.Walter, M., et al. Prediction of autonomic dysreflexia during urodynamics: a prospective cohort study. BMC Med, 2018. 16: 53.
https://pubmed.ncbi.nlm.nih.gov/29650001
98.Liu, N., et al. Autonomic dysreflexia severity during urodynamics and cystoscopy in individuals with spinal cord injury. Spinal Cord, 2013. 51: 863.
https://pubmed.ncbi.nlm.nih.gov/24060768
99.Labat, J.J., et al. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn, 2008. 27: 306.
https://pubmed.ncbi.nlm.nih.gov/17828787
100.Brown, D., Atlas of regional anesthesia. 3rd. ed. 2006, Philadelphia
101.Standring, S., Gray’s anatomy, . 40th ed. 2008.
102.Bellucci, C.H., et al. Neurogenic lower urinary tract dysfunction--do we need same session repeat urodynamic investigations? J Urol, 2012. 187: 1318.
https://pubmed.ncbi.nlm.nih.gov/22341264
103.Walter, M., et al. Autonomic dysreflexia and repeatability of cardiovascular changes during same session repeat urodynamic investigation in women with spinal cord injury. World J Urol, 2016. 34: 391.
https://pubmed.ncbi.nlm.nih.gov/26055644
104.Gammie, A., et al. International Continence Society guidelines on urodynamic equipment performance. Neurourol Urodyn, 2014. 33: 370.
https://pubmed.ncbi.nlm.nih.gov/24390971
105.Anderson, C.E., et al. Temporal development of unfavourable urodynamic parameters during the first year after spinal cord injury. BJU Int, 2023. 131: 503.
https://pubmed.ncbi.nlm.nih.gov/36221991
106.Kozomara, M., et al. Neurogenic Lower Urinary Tract Dysfunction in the First Year After Spinal Cord Injury: A Descriptive Study of Urodynamic Findings. J Urol, 2023. 209: 225.
https://pubmed.ncbi.nlm.nih.gov/36263681
107.McGuire, E.J., et al. Leak-point pressures. Urol Clin North Am, 1996. 23: 253.
https://pubmed.ncbi.nlm.nih.gov/8659025
108.Ozkan, B., et al. Which factors predict upper urinary tract deterioration in overactive neurogenic bladder dysfunction? Urology, 2005. 66: 99.
https://pubmed.ncbi.nlm.nih.gov/15992868
109.Wang, Q.W., et al. Is it possible to use urodynamic variables to predict upper urinary tract dilatation in children with neurogenic bladder-sphincter dysfunction? BJU Int, 2006. 98: 1295.
https://pubmed.ncbi.nlm.nih.gov/17034510
110.Linsenmeyer, T.A., et al. The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med, 1998. 21: 15.
https://pubmed.ncbi.nlm.nih.gov/9541882
111.McGuire, E.J., et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol, 1981. 126: 205.
https://pubmed.ncbi.nlm.nih.gov/7196460
112.Krongrad, A., et al. Bladder neck dysynergia in spinal cord injury. Am J Phys Med Rehabil, 1996. 75: 204.
https://pubmed.ncbi.nlm.nih.gov/8663928
113.Weld, K.J., et al. Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology, 2000. 56: 565.
https://pubmed.ncbi.nlm.nih.gov/11018603
114.Rossier, A.B., et al. 5-microtransducer catheter in evaluation of neurogenic bladder function. Urology, 1986. 27: 371.
https://pubmed.ncbi.nlm.nih.gov/3962062
115.Al-Ali, M., et al. A 10 year review of the endoscopic treatment of 125 spinal cord injured patients with vesical outlet obstruction: does bladder neck dyssynergia exist? Paraplegia, 1996. 34: 34.
https://pubmed.ncbi.nlm.nih.gov/8848321
116.Bacsu, C.D., et al. Diagnosing detrusor sphincter dyssynergia in the neurological patient. BJU Int, 2012. 109 Suppl 3: 31.
https://pubmed.ncbi.nlm.nih.gov/22458490
117.Lose, G., et al. Standardisation of urethral pressure measurement: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 258.
https://pubmed.ncbi.nlm.nih.gov/11948719
118.Marks, B.K., et al. Videourodynamics: indications and technique. Urol Clin North Am, 2014. 41: 383.
https://pubmed.ncbi.nlm.nih.gov/25063594
119.Virseda, M., et al. Reliability of ambulatory urodynamics in patients with spinal cord injuries. Neurourol Urodyn, 2013. 32: 387.
https://pubmed.ncbi.nlm.nih.gov/23002043
120.Virseda-Chamorro, M., et al. Comparison of ambulatory versus video urodynamics in patients with spinal cord injury. Spinal Cord, 2014. 52: 551.
https://pubmed.ncbi.nlm.nih.gov/24663000
121.Geirsson, G., et al. The ice-water test--a simple and valuable supplement to routine cystometry. Br J Urol, 1993. 71: 681.
https://pubmed.ncbi.nlm.nih.gov/8343894
122.Geirsson, G., et al. Pressure, volume and infusion speed criteria for the ice-water test. Br J Urol, 1994. 73: 498.
https://pubmed.ncbi.nlm.nih.gov/8012770
123.Kozomara, M., et al. Is Detrusor Contraction during Rapid Bladder Filling Caused by Cold or Warm Water? A Randomized, Controlled, Double-Blind Trial. J Urol, 2018. 199: 223.
https://pubmed.ncbi.nlm.nih.gov/28751267
124.Al-Hayek, S., et al. The 50-year history of the ice water test in urology. J Urol, 2010. 183: 1686.
https://pubmed.ncbi.nlm.nih.gov/20299050
125.Lapides, J. Neurogenic bladder. Principles of treatment. Urol Clin North Am, 1974. 1: 81.
https://pubmed.ncbi.nlm.nih.gov/4428540
126.Riedl, C.R., et al. Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol, 2000. 164: 2108.
https://pubmed.ncbi.nlm.nih.gov/11061937
127.Podnar, S., et al. Lower urinary tract dysfunction in patients with peripheral nervous system lesions. Handb Clin Neurol, 2015. 130: 203.
https://pubmed.ncbi.nlm.nih.gov/26003246
128.Ouyang, L., et al. Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system. J Urol, 2015. 193: 558.
https://pubmed.ncbi.nlm.nih.gov/25167993
129.Lane, G.I., et al. Clinical outcomes of non-surgical management of detrusor leak point pressures above 40 cm water in adults with congenital neurogenic bladder. Neurourol Urodyn, 2018. 37: 1943.
https://pubmed.ncbi.nlm.nih.gov/29488655
130.Lawrenson, R., et al. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology, 2001. 20: 138.
https://pubmed.ncbi.nlm.nih.gov/11359083
131.Mingat, N., et al. Prospective study of methods of renal function evaluation in patients with neurogenic bladder dysfunction. Urology, 2013. 82: 1032.
https://pubmed.ncbi.nlm.nih.gov/24001705
132.Averbeck, M.A., et al. Follow-up of the neuro-urological patient: a systematic review. BJU Int, 2015. 115 Suppl 6: 39.
https://pubmed.ncbi.nlm.nih.gov/25891319
133.Stöhrer, M., et al. Diagnosis and treatment of bladder dysfunction in spinal cord injury patients. Eur Urol Update Series 1994. 3: 170.
134.Apostolidis, A., et al., Neurologic Urinary and Faecal Incontinence, in Incontinence 6th Edition, P. Abrams, L. Cardozo, S. Khoury & A. Wein, Editors. 2017.
135.Chamberlain, J.D., et al. Mortality and longevity after a spinal cord injury: systematic review and meta-analysis. Neuroepidemiology, 2015. 44: 182.
https://pubmed.ncbi.nlm.nih.gov/25997873
136.Game, X., et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol, 2008. 53: 613.
https://pubmed.ncbi.nlm.nih.gov/17804150
137.Frankel, H.L., et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord, 1998. 36: 266.
https://pubmed.ncbi.nlm.nih.gov/9589527
138.Jamil, F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal Cord, 2001. 39: 355.
https://pubmed.ncbi.nlm.nih.gov/11464308
139.Thietje, R., et al. Mortality in patients with traumatic spinal cord injury: descriptive analysis of 62 deceased subjects. J Spinal Cord Med, 2011. 34: 482.
https://pubmed.ncbi.nlm.nih.gov/22118255
140.Hackler, R.H. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol, 1977. 117: 486.
https://pubmed.ncbi.nlm.nih.gov/850323
141.Rodrigues, P., et al. Involuntary detrusor contraction is a frequent finding in patients with recurrent urinary tract infections. Urol Int, 2014. 93: 67.
https://pubmed.ncbi.nlm.nih.gov/25011551
142.Bauer, S.B. Neurogenic bladder: etiology and assessment. Pediatr Nephrol, 2008. 23: 541.
https://pubmed.ncbi.nlm.nih.gov/18270749
143.Barbalias, G.A., et al. Critical evaluation of the Crede maneuver: a urodynamic study of 207 patients. J Urol, 1983. 130: 720.
https://pubmed.ncbi.nlm.nih.gov/6887405
144.Reinberg, Y., et al. Renal rupture after the Crede maneuver. J Pediatr, 1994. 124: 279.
https://pubmed.ncbi.nlm.nih.gov/8301439
145.Wyndaele, J.J., et al. Neurologic urinary incontinence. Neurourol Urodyn, 2010. 29: 159.
https://pubmed.ncbi.nlm.nih.gov/20025021
146.Menon, E.B., et al. Bladder training in patients with spinal cord injury. Urology, 1992. 40: 425.
https://pubmed.ncbi.nlm.nih.gov/1441039
147.Furusawa, K., et al. Incidence of symptomatic autonomic dysreflexia varies according to the bowel and bladder management techniques in patients with spinal cord injury. Spinal Cord, 2011. 49: 49.
https://pubmed.ncbi.nlm.nih.gov/20697419
148.Consortium for Spinal Cord, M. Outcomes following traumatic spinal cord injury: clinical practice guidelines for health-care professionals. J Spinal Cord Med, 2000. 23: 289.
https://pubmed.ncbi.nlm.nih.gov/17536300
149.El-Masri, W.S., et al. Long-term follow-up study of outcomes of bladder management in spinal cord injury patients under the care of the Midlands Centre for Spinal Injuries in Oswestry. Spinal Cord, 2012. 50: 14.
https://pubmed.ncbi.nlm.nih.gov/21808256
150.Fall, M., et al. Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin North Am, 1991. 18: 393.
https://pubmed.ncbi.nlm.nih.gov/2017820
151.Sundin, T., et al. Detrusor inhibition induced from mechanical stimulation of the anal region and from electrical stimulation of pudendal nerve afferents. An experimental study in cats. Invest Urol, 1974. 11: 374.
https://pubmed.ncbi.nlm.nih.gov/4815623
152.Gross, T., et al. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. Eur Urol, 2016. 69: 1102.
https://pubmed.ncbi.nlm.nih.gov/26831506
153.Vaughan, C.P., et al. Behavioral therapy for urinary symptoms in Parkinson’s disease: A randomized clinical trial. Neurourol Urodyn, 2019. 38: 1737.
https://pubmed.ncbi.nlm.nih.gov/31187552
154.McDonald, C., et al. Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial. Neurology, 2020. 94: e1427.
https://pubmed.ncbi.nlm.nih.gov/32054791
155.Ozden, F., et al. The effect of pelvic floor muscle training on urinary incontinence in patients with stroke: a systematic review and meta-analysis. Ir J Med Sci, 2023. 192: 1481.
https://pubmed.ncbi.nlm.nih.gov/35776264
156.Kajbafvala, M., et al. Pelvic floor muscle training in multiple sclerosis patients with lower urinary tract dysfunction: A systematic review and meta-analysis. Mult Scler Relat Disord, 2022. 59: 103559.
https://pubmed.ncbi.nlm.nih.gov/35144089
157.Bapir, R., et al. Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials. Arch Ital Urol Androl, 2022. 94: 492.
https://pubmed.ncbi.nlm.nih.gov/36576454
158.Ali, M.U., et al. Effects of nonsurgical, minimally or noninvasive therapies for urinary incontinence due to neurogenic bladder: a systematic review and meta-analysis. Ther Adv Chronic Dis, 2022. 13: 20406223211063059.
https://pubmed.ncbi.nlm.nih.gov/35321402
159.Liu, Y., et al. Effects of Transcutaneous Electrical Nerve Stimulation at Two Frequencies on Urinary Incontinence in Poststroke Patients: A Randomized Controlled Trial. Am J Phys Med Rehabil, 2016. 95: 183.
https://pubmed.ncbi.nlm.nih.gov/26259053
160.Guo, G.Y., et al. Effectiveness of neuromuscular electrical stimulation therapy in patients with urinary incontinence after stroke: A randomized sham controlled trial. Medicine (Baltimore), 2018. 97: e13702.
https://pubmed.ncbi.nlm.nih.gov/30593142
161.Shen, S.X., et al. A retrospective study of neuromuscular electrical stimulation for treating women with post-stroke incontinence. Medicine (Baltimore), 2018. 97: e11264.
https://pubmed.ncbi.nlm.nih.gov/29952999
162.Marzouk, M.H., et al. Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study. Mult Scler Relat Disord, 2022. 68: 104252.
https://pubmed.ncbi.nlm.nih.gov/36274285
163.Smith, M.D., et al. Neuromodulation for Storage Lower Urinary Tract Symptoms in Parkinson Disease: A Systematic Review. Neuromodulation, 2022. 25: 1076.
https://pubmed.ncbi.nlm.nih.gov/35300922
164.Stampas, A., et al. Bladder Neuromodulation in Acute Spinal Cord Injury via Transcutaneous Tibial Nerve Stimulation: Cystometrogram and Autonomic Nervous System Evidence From a Randomized Control Pilot Trial. Front Neurosci, 2019. 13: 119.
https://pubmed.ncbi.nlm.nih.gov/30837835
165.Stampas, A., et al. Safety, Feasibility, and Efficacy of Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury Neurogenic Bladder: A Randomized Control Pilot Trial. Neuromodulation, 2019. 22: 716.
https://pubmed.ncbi.nlm.nih.gov/30284350
166.Parittotokkaporn, S., et al. Non-invasive neuromodulation for bowel, bladder and sexual restoration following spinal cord injury: A systematic review. Clin Neurol Neurosurg, 2020. 194: 105822.
https://pubmed.ncbi.nlm.nih.gov/32334284
167.Daia, C., et al. Interferential electrical stimulation for improved bladder management following spinal cord injury. Biomed Rep, 2019. 11: 115.
https://pubmed.ncbi.nlm.nih.gov/31423306
168.McClurg, D., et al. Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis--a double blind, placebo controlled, randomised clinical trial. Neurourol Urodyn, 2008. 27: 231.
https://pubmed.ncbi.nlm.nih.gov/17705160
169.Silva Ferreira, A.P., et al. A Controlled Clinical Trial on the Effects of Exercise on Lower Urinary Tract Symptoms in Women With Multiple Sclerosis. Am J Phys Med Rehabil, 2019. 98: 777.
https://pubmed.ncbi.nlm.nih.gov/30932917
170.McClurg, D., et al. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn, 2006. 25: 337.
https://pubmed.ncbi.nlm.nih.gov/16637070
171.Ferreira, A.P., et al. Impact of a Pelvic Floor Training Program Among Women with Multiple Sclerosis: A Controlled Clinical Trial. Am J Phys Med Rehabil, 2016. 95: 1.
https://pubmed.ncbi.nlm.nih.gov/25888662
172.Elmelund, M., et al. The effect of pelvic floor muscle training and intravaginal electrical stimulation on urinary incontinence in women with incomplete spinal cord injury: an investigator-blinded parallel randomized clinical trial. Int Urogynecol J, 2018. 29: 1597.
https://pubmed.ncbi.nlm.nih.gov/29574482
173.Hagerty, J.A., et al. Intravesical electrotherapy for neurogenic bladder dysfunction: a 22-year experience. J Urol, 2007. 178: 1680.
https://pubmed.ncbi.nlm.nih.gov/17707024
174.Primus, G., et al. Restoration of micturition in patients with acontractile and hypocontractile detrusor by transurethral electrical bladder stimulation. Neurourol Urodyn, 1996. 15: 489.
https://pubmed.ncbi.nlm.nih.gov/8857617
175.Lombardi, G., et al. Clinical efficacy of intravesical electrostimulation on incomplete spinal cord patients suffering from chronic neurogenic non-obstructive retention: a 15-year single centre retrospective study. Spinal Cord, 2013. 51: 232.
https://pubmed.ncbi.nlm.nih.gov/23147136
176.Nardone, R., et al. Transcranial magnetic stimulation and bladder function: A systematic review. Clin Neurophysiol, 2019. 130: 2032.
https://pubmed.ncbi.nlm.nih.gov/31541980
177.El-Habashy, H., et al. The effect of cortical versus sacral repetitive magnetic stimulation on lower urinary tract dysfunction in patients with multiple sclerosis. Acta Neurol Belg, 2020. 120: 141.
https://pubmed.ncbi.nlm.nih.gov/31828602
178.Thomas, L.H., et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev, 2008. 2008: CD004462.
https://pubmed.ncbi.nlm.nih.gov/18254050
179.Yeo, L., et al. Urinary tract dysfunction in Parkinson’s disease: a review. Int Urol Nephrol, 2012. 44: 415.
https://pubmed.ncbi.nlm.nih.gov/21553114
180.Phe, V., et al. Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol, 2016. 13: 275.
https://pubmed.ncbi.nlm.nih.gov/27030526
181.Andersson, K.E. Antimuscarinic mechanisms and the overactive detrusor: an update. Eur Urol, 2011. 59: 377.
https://pubmed.ncbi.nlm.nih.gov/21168951
182.Bennett, N., et al. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol, 2004. 171: 749.
https://pubmed.ncbi.nlm.nih.gov/14713802
183.Horstmann, M., et al. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol Urodyn, 2006. 25: 441.
https://pubmed.ncbi.nlm.nih.gov/16847942
184.Kennelly, M.J., et al. Overactive bladder: pharmacologic treatments in the neurogenic population. Rev Urol, 2008. 10: 182.
https://pubmed.ncbi.nlm.nih.gov/18836537
185.Madersbacher, H., et al. Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord, 2013. 51: 432.
https://pubmed.ncbi.nlm.nih.gov/23743498
186.Madhuvrata, P., et al. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. Eur Urol, 2012. 62: 816.
https://pubmed.ncbi.nlm.nih.gov/22397851
187.Stohrer, M., et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol, 2009. 56: 81.
https://pubmed.ncbi.nlm.nih.gov/19403235
188.Mehnert, U., et al. The management of urinary incontinence in the male neurological patient. Curr Opin Urol, 2014. 24: 586.
https://pubmed.ncbi.nlm.nih.gov/25389549
189.Stothers, L., et al. An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction. Spinal Cord, 2016. 54: 1114.
https://pubmed.ncbi.nlm.nih.gov/27241452
190.Amend, B., et al. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol, 2008. 53: 1021.
https://pubmed.ncbi.nlm.nih.gov/18243516
191.Cameron, A.P. Pharmacologic therapy for the neurogenic bladder. Urol Clin North Am, 2010. 37: 495.
https://pubmed.ncbi.nlm.nih.gov/20955901
192.Menarini, M., et al. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients? Int J Clin Pharmacol Ther, 2006. 44: 623.
https://pubmed.ncbi.nlm.nih.gov/17190372
193.Nardulli, R., et al. Combined antimuscarinics for treatment of neurogenic overactive bladder. Int J Immunopathol Pharmacol, 2012. 25: 35S.
https://pubmed.ncbi.nlm.nih.gov/22652160
194.Tijnagel, M.J., et al. Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin. BMC Urol, 2017. 17: 30.
https://pubmed.ncbi.nlm.nih.gov/28403849
195.Cameron, A.P., et al. Combination drug therapy improves compliance of the neurogenic bladder. J Urol, 2009. 182: 1062.
https://pubmed.ncbi.nlm.nih.gov/19616807
196.Isik, A.T., et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging, 2009. 13: 672.
https://pubmed.ncbi.nlm.nih.gov/19657549
197.Ethans, K.D., et al. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med, 2004. 27: 214.
https://pubmed.ncbi.nlm.nih.gov/15478523
198.McKeage, K. Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms. Clin Drug Investig, 2013. 33: 71.
https://pubmed.ncbi.nlm.nih.gov/23288694
199.Nicholas, R.S., et al. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev, 2009: CD004193.
https://pubmed.ncbi.nlm.nih.gov/19160231
200.van Rey, F., et al. Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study. Adv Urol, 2011. 2011: 834753.
https://pubmed.ncbi.nlm.nih.gov/21687581
201.Bycroft, J., et al. The effect of darifenacin on neurogenic detrusor overactivity in patients with spinal cord injury. Neurourol Urodyn 2003. 22: A190.
https://www.ics.org/Abstracts/Publish/41/000190.pdf
202.Carl, S., et al. Up-01.88. Urology, 2006. 68: 250.
https://www.goldjournal.net/article/S0090-4295(06)01724-9/fulltext
203.Amarenco, G., et al. Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study. Neurourol Urodyn, 2017. 36: 414.
https://pubmed.ncbi.nlm.nih.gov/26714009
204.Zesiewicz, T.A., et al. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson’s disease. Parkinsonism Relat Disord, 2015. 21: 514.
https://pubmed.ncbi.nlm.nih.gov/25814050
205.Yonguc, T., et al. Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson’s disease. World J Urol, 2020. 38: 2013.
https://pubmed.ncbi.nlm.nih.gov/31642953
206.Konstantinidis, C., et al. Efficacy of fesoterodine fumarate (8 mg) in neurogenic detrusor overactivity due to spinal cord lesion or multiple sclerosis: A prospective study. Neurourol Urodyn, 2021. 40: 2026.
https://pubmed.ncbi.nlm.nih.gov/34498773
207.Walter, M., et al. Fesoterodine Ameliorates Autonomic Dysreflexia While Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals With Spinal Cord Injury: A Prospective Phase IIa Study. J Neurotrauma, 2023. 40: 1020.
https://pubmed.ncbi.nlm.nih.gov/36178342
208.Sakakibara, R., et al. Imidafenacin on bladder and cognitive function in neurologic OAB patients. Clin Auton Res, 2013. 23: 189.
https://pubmed.ncbi.nlm.nih.gov/23820664
209.Sugiyama, H., et al. Effect of imidafenacin on the urodynamic parameters of patients with indwelling bladder catheters due to spinal cord injury. Spinal Cord, 2017. 55: 187.
https://pubmed.ncbi.nlm.nih.gov/27897185
210.Stohrer, M., et al. Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity. Spinal Cord, 2013. 51: 419.
https://pubmed.ncbi.nlm.nih.gov/23338657
211.Schroder, A., et al. Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi-center trial. Neurourol Urodyn, 2016. 35: 582.
https://pubmed.ncbi.nlm.nih.gov/25754454
212.Dmochowski, R.R., et al. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis. Neurourol Urodyn, 2021. 40: 28.
https://pubmed.ncbi.nlm.nih.gov/33098213
213.Trbovich, M., et al. The treatment of neurogenic lower urinary tract dysfunction in persons with spinal cord injury: An open label, pilot study of anticholinergic agent vs. mirabegron to evaluate cognitive impact and efficacy. Spinal Cord Ser Cases, 2021. 7: 50.
https://pubmed.ncbi.nlm.nih.gov/34112758
214.El Helou, E., et al. The use of mirabegron in neurogenic bladder: a systematic review. World J Urol, 2020. 38: 2435.
https://pubmed.ncbi.nlm.nih.gov/31802206
215.Glykas, I., et al. B3 agonists or anticholinergics in the treatment of the lower urinary tract dysfunction in patients with multiple sclerosis?-A randomized study. World J Urol, 2021. 39: 3049.
https://pubmed.ncbi.nlm.nih.gov/33386947
216.Krhut, J., et al. Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study. Neurourol Urodyn, 2018. 37: 2226.
https://pubmed.ncbi.nlm.nih.gov/29603781
217.Akkoc, Y. Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review. Spinal Cord, 2022. 60: 854.
https://pubmed.ncbi.nlm.nih.gov/36085413
218.Krhut, J., et al. Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity. Int Urol Nephrol, 2021. 53: 1089.
https://pubmed.ncbi.nlm.nih.gov/33417146
219.Chen, S.F., et al. Therapeutic efficacy of low‐dose (251398042195mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases. LUTS: Lower Urinary Tract Symptoms, 2018. 11: O53.
https://pubmed.ncbi.nlm.nih.gov/29380517
220.Cho, S.Y., et al. Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson’s disease: A double-blind, randomized placebo-controlled trial (Parkinson’s Disease Overactive bladder Mirabegron, PaDoMi Study). Neurourol Urodyn, 2021. 40: 286.
https://pubmed.ncbi.nlm.nih.gov/33389776
221.Matsuda, K., et al. Urodynamic effect of vibegron on neurogenic lower urinary tract dysfunction in individuals with spinal cord injury: A retrospective study. Spinal Cord, 2022. 60: 716.
https://pubmed.ncbi.nlm.nih.gov/35177800
222.Phe, V., et al. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn, 2019. 38: 563.
https://pubmed.ncbi.nlm.nih.gov/30653737
223.Zachariou, A., et al. Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. The Canadian journal of urology, 2017. 24: 9107.
https://pubmed.ncbi.nlm.nih.gov/29260636
224.Moussa, M., et al. The safety and effectiveness of mirabegron in Parkinson’s disease patients with overactive bladder: a randomized controlled trial. Scand J Urol, 2022. 56: 66.
https://pubmed.ncbi.nlm.nih.gov/34672847
225.Abo Youssef, N., et al. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis. BJU Int, 2017. 119: 515.
https://pubmed.ncbi.nlm.nih.gov/28058780
226.Torri Clerici, V., et al. Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study. Mult Scler Relat Disord, 2023. 74: 104711.
https://pubmed.ncbi.nlm.nih.gov/37062198
227.Francomano, D., et al. Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study. J Endocrinol Invest, 2017. 40: 275.
https://pubmed.ncbi.nlm.nih.gov/27752863
228.Barendrecht, M.M., et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int, 2007. 99: 749.
https://pubmed.ncbi.nlm.nih.gov/17233798
229.Apostolidis, A. Taming the cannabinoids: new potential in the pharmacologic control of lower urinary tract dysfunction. Eur Urol, 2012. 61: 107.
https://pubmed.ncbi.nlm.nih.gov/21996529
230.Gratzke, C., et al. Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol, 2010. 57: 1093.
https://pubmed.ncbi.nlm.nih.gov/20207474
231.Abrams, P., et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol, 2003. 170: 1242.
https://pubmed.ncbi.nlm.nih.gov/14501734
232.Gomes, C.M., et al. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson’s disease. Clinics (Sao Paulo), 2014. 69: 817.
https://pubmed.ncbi.nlm.nih.gov/25627993
233.Moon, K.H., et al. A 12-Week, Open Label, Multi-Center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction in Patients with Neurogenic Bladder. Low Urin Tract Symptoms, 2015. 7: 27.
https://pubmed.ncbi.nlm.nih.gov/26663648
234.Schneider, M.P., et al. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn, 2019. 38: 1482.
https://pubmed.ncbi.nlm.nih.gov/31099113
235.Sung, H.H., et al. Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design. Int Neurourol J, 2020. 24: 163.
https://pubmed.ncbi.nlm.nih.gov/32615679
236.Guttmann, L., et al. The value of intermittent catheterisation in the early management of traumatic paraplegia and tetraplegia. Paraplegia, 1966. 4: 63.
https://pubmed.ncbi.nlm.nih.gov/5969402
237.Lapides, J., et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol, 1972. 107: 458.
https://pubmed.ncbi.nlm.nih.gov/5010715
238.Elliott, C.S., et al. Validation of Upper Extremity Motor Function as a Key Predictor of Bladder Management After Spinal Cord Injury. Arch Phys Med Rehabil, 2019. 100: 1939.
https://pubmed.ncbi.nlm.nih.gov/31348899
239.Jamison, J., et al. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochrane Database Syst Rev, 2013. 11: CD004375.
https://pubmed.ncbi.nlm.nih.gov/24249436
240.Prieto-Fingerhut, T., et al. A study comparing sterile and nonsterile urethral catheterization in patients with spinal cord injury. Rehabil Nurs, 1997. 22: 299.
https://pubmed.ncbi.nlm.nih.gov/9416190
241.Corona, L.E., et al. Intermittent catheterization and urinary tract infection in multiple sclerosis patients. Can J Urol, 2020. 27: 10294.
https://pubmed.ncbi.nlm.nih.gov/32861254
242.Crescenze, I.M., et al. Predictors of low urinary quality of life in spinal cord injury patients on clean intermittent catheterization. Neurourol Urodyn, 2019. 38: 1332.
https://pubmed.ncbi.nlm.nih.gov/30912199
243.Patel, D.P., et al. Reasons for cessation of clean intermittent catheterization after spinal cord injury: Results from the Neurogenic Bladder Research Group spinal cord injury registry. Neurourol Urodyn, 2020. 39: 211.
https://pubmed.ncbi.nlm.nih.gov/31578784
244.Goetz, L.L., et al. International Spinal Cord Injury Urinary Tract Infection Basic Data Set. Spinal Cord, 2013. 51: 700.
https://pubmed.ncbi.nlm.nih.gov/23896666
245.Bakke, A., et al. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol, 1997. 79: 85.
https://pubmed.ncbi.nlm.nih.gov/9043503
246.Günther, M., et al. Auswirkungen des aseptischen intermittierenden Katheterismus auf die männliche Harnröhre. Der Urologe B, 2001. 41: 359.
https://link.springer.com/article/10.1007/s00131-002-0207-x
247.Kurze, I., et al. Intermittent Catheterisation and Prevention of Urinary Tract Infections in Patients with Neurogenic Lower Urinary Tract Dysfunction - Best PracticeAn Overview. [German]. Aktuelle Neurologie, 2015. 42: 515.
248.Waller, L., et al. Clean intermittent catheterization in spinal cord injury patients: long-term followup of a hydrophilic low friction technique. J Urol, 1995. 153: 345.
https://pubmed.ncbi.nlm.nih.gov/7815579
249.Wyndaele, J.J. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord, 2002. 40: 536.
https://pubmed.ncbi.nlm.nih.gov/12235537
250.Woodbury, M.G., et al. Intermittent catheterization practices following spinal cord injury: a national survey. Can J Urol, 2008. 15: 4065.
https://pubmed.ncbi.nlm.nih.gov/18570710
251.Bennett, C.J., et al. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol, 1995. 153: 1458.
https://pubmed.ncbi.nlm.nih.gov/7714965
252.Chao, R., et al. Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury. Urology, 1993. 42: 259.
https://pubmed.ncbi.nlm.nih.gov/8379025
253.Larsen, L.D., et al. Retrospective analysis of urologic complications in male patients with spinal cord injury managed with and without indwelling urinary catheters. Urology, 1997. 50: 418.
https://pubmed.ncbi.nlm.nih.gov/9301708
254.Mitsui, T., et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol, 2000. 38: 434.
https://pubmed.ncbi.nlm.nih.gov/11025382
255.Weld, K.J., et al. Effect of bladder management on urological complications in spinal cord injured patients. J Urol, 2000. 163: 768.
https://pubmed.ncbi.nlm.nih.gov/10687973
256.Weld, K.J., et al. Influences on renal function in chronic spinal cord injured patients. J Urol, 2000. 164: 1490.
https://pubmed.ncbi.nlm.nih.gov/11025689
257.Lavelle, R.S., et al. Quality of life after suprapubic catheter placement in patients with neurogenic bladder conditions. Neurourol Urodyn, 2016. 35: 831.
https://pubmed.ncbi.nlm.nih.gov/26197729
258.Hird, A.E., et al. Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada. BMJ Open, 2021. 11: e050728.
https://pubmed.ncbi.nlm.nih.gov/34475180
259.Hollingsworth, J.M., et al. Determining the noninfectious complications of indwelling urethral catheters: a systematic review and meta-analysis. Ann Intern Med, 2013. 159: 401.
https://pubmed.ncbi.nlm.nih.gov/24042368
260.Ismail, S., et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review. Neurourol Urodyn, 2018. 37: 1386.
https://pubmed.ncbi.nlm.nih.gov/29168217
261.Shen, S.H., et al. Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: a systematic review and meta-analysis. Int Urol Nephrol, 2022. 54: 737.
https://pubmed.ncbi.nlm.nih.gov/35226282
262.Buyse, G., et al. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol, 1998. 160: 892.
https://pubmed.ncbi.nlm.nih.gov/9720583
263.Di Stasi, S.M., et al. Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. J Urol, 2001. 166: 2232.
https://pubmed.ncbi.nlm.nih.gov/11696741
264.Giannantoni, A., et al. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol, 2004. 172: 240.
https://pubmed.ncbi.nlm.nih.gov/15201783
265.Kim, J.H., et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med, 2003. 26: 358.
https://pubmed.ncbi.nlm.nih.gov/14992337
266.Del Popolo, G., et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol, 2008. 53: 1013.
https://pubmed.ncbi.nlm.nih.gov/17950989
267.Reitz, A., et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol, 2004. 45: 510.
https://pubmed.ncbi.nlm.nih.gov/15041117
268.Yuan, H., et al. Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis. International Neurourology Journal, 2017. 21: 53.
https://pubmed.ncbi.nlm.nih.gov/28361515
269.Cheng, T., et al. Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One, 2016. 11: e0159307.
https://pubmed.ncbi.nlm.nih.gov/27463810
270.Wagle Shukla, A., et al. Botulinum Toxin Therapy for Parkinson’s Disease. Semin Neurol, 2017. 37: 193.
https://pubmed.ncbi.nlm.nih.gov/28511260
271.Wu, S.J., et al. Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis. Ren Fail, 2019. 41: 937.
https://pubmed.ncbi.nlm.nih.gov/31599184
272.Chen, S.F., et al. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury. Toxins (Basel), 2022. 14.
https://pubmed.ncbi.nlm.nih.gov/35051012
273.Baron, M., et al. Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study. J Urol, 2019. 201: 769.
https://pubmed.ncbi.nlm.nih.gov/30359679
274.Leitner, L., et al. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned. Eur Urol, 2016. 70: 522.
https://pubmed.ncbi.nlm.nih.gov/27106070
275.Koschorke, M., et al. Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment? BJU Int, 2017. 120: 848.
https://pubmed.ncbi.nlm.nih.gov/28771936
276.Ginsberg, D., et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol, 2012. 187: 2131.
https://pubmed.ncbi.nlm.nih.gov/22503020
277.Grosse, J., et al. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol, 2005. 47: 653.
https://pubmed.ncbi.nlm.nih.gov/15826758
278.Rovner, E., et al. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol, 2016. 196: 801.
https://pubmed.ncbi.nlm.nih.gov/27091236
279.Ni, J., et al. Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity-A systematic review and meta-analysis. Neurourol Urodyn, 2018. 37: 542.
https://pubmed.ncbi.nlm.nih.gov/28745818
280.Michel, F., et al. Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study. Urology, 2019. 129: 43.
https://pubmed.ncbi.nlm.nih.gov/30926380
281.Toia, B., et al. The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature review. Neurourol Urodyn, 2020. 39: 1831.
https://pubmed.ncbi.nlm.nih.gov/32572987
282.Giannantoni, A., et al. IncobotulinumtoxinA versus onabotulinumtoxinA intradetrusor injections in patients with neurogenic detrusor overactivity incontinence: a double-blind, randomized, non-inferiority trial. Minerva Urol Nephrol, 2022. 74: 625.
https://pubmed.ncbi.nlm.nih.gov/33769020
283.Cruz, F., et al. Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison. J Med Econ, 2023. 26: 200.
https://pubmed.ncbi.nlm.nih.gov/36647624
284.Bottet, F., et al. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourol Urodyn, 2018. 37: 291.
https://pubmed.ncbi.nlm.nih.gov/28431196
285.Leu, R., et al. Complications of Botox and their Management. Current Urology Reports, 2018. 19: 90.
https://pubmed.ncbi.nlm.nih.gov/30194497
286.Tullman, M., et al. Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS. Neurology, 2018. 91: e657.
https://pubmed.ncbi.nlm.nih.gov/30030330
287.Cui, Y., et al. Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis. Front Neurol, 2021. 12: 651635.
https://pubmed.ncbi.nlm.nih.gov/34690904
288.Tyagi, P., et al. Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder. J Urol, 2017. 197: 982.
https://pubmed.ncbi.nlm.nih.gov/27871929
289.Young, M.J., et al. Another Therapeutic Role for Intravesical Botulinum Toxin: Patients with Long-stay Catheters and Refractory Bladder Pain and Catheter Bypass Leakage. Eur Urol Focus, 2020. 6: 339.
https://pubmed.ncbi.nlm.nih.gov/30392867
290.Wu, S.Y., et al. Satisfaction with Surgical Procedures and Bladder Management of Chronic Spinal Cord Injured Patients with Voiding Dysfunction Who Desire Spontaneous Voiding. J Pers Med, 2022. 12.
https://pubmed.ncbi.nlm.nih.gov/36294890
291.Lee, C.L., et al. Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction. Toxins (Basel), 2022. 14.
https://pubmed.ncbi.nlm.nih.gov/35051007
292.Popat, S., et al. Sphincteric Injection of Botulinum Toxin for Urinary Retention due to Neurogenic Bladder. Current Bladder Dysfunction Reports, 2022. 17: 179.
https://link.springer.com/article/10.1007/s11884-022-00657-4
293.Utomo, E., et al. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction. Cochrane Database Syst Rev, 2014. 5: CD004927.
https://pubmed.ncbi.nlm.nih.gov/24859260
294.Bennett, J.K., et al. Collagen injections for intrinsic sphincter deficiency in the neuropathic urethra. Paraplegia, 1995. 33: 697.
https://pubmed.ncbi.nlm.nih.gov/8927407
295.Block, C.A., et al. Long-term efficacy of periurethral collagen injection for the treatment of urinary incontinence secondary to myelomeningocele. J Urol, 2003. 169: 327.
https://pubmed.ncbi.nlm.nih.gov/12478183
296.Schurch, B., et al. Intraurethral sphincter prosthesis to treat hyporeflexic bladders in women: does it work? BJU Int, 1999. 84: 789.
https://pubmed.ncbi.nlm.nih.gov/10532973
297.Reuvers, S.H.M., et al. Heterogeneity in reporting on urinary outcome and cure after surgical interventions for stress urinary incontinence in adult neuro-urological patients: A systematic review. Neurourol Urodyn, 2018. 37: 554.
https://pubmed.ncbi.nlm.nih.gov/28792081
298.Cardozo, L., et al., Incontinence 7th Edition ICI-ICS. Vol. 7th 2023, Bristol, UK.
299.Barthold, J.S., et al. Results of the rectus fascial sling and wrap procedures for the treatment of neurogenic sphincteric incontinence. J Urol, 1999. 161: 272.
https://pubmed.ncbi.nlm.nih.gov/10037423
300.Musco, S., et al. Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review. Eur Urol Focus, 2022. 8: 1090.
https://pubmed.ncbi.nlm.nih.gov/34509413
301.Sarrazin, C., et al. Synthetic Mid-urethral Sling for the Treatment of Urinary Incontinence in Women With Neurogenic Lower Urinary Tract Dysfunction: A Multicentric Retrospective Study. J Urol, 2023. 209: 1176.
https://pubmed.ncbi.nlm.nih.gov/36812396
302.Pannek, J., et al. Management of stress urinary incontinence in female patients with spinal cord injury by autologous fascial sling: time for a revival? Spinal Cord Ser Cases, 2022. 8: 57.
https://pubmed.ncbi.nlm.nih.gov/35610208
303.Deytrikh, A., et al. Autologous fascial slings for stress urinary incontinence in patients with neuropathic bladder. Spinal Cord Ser Cases, 2022. 8: 25.
https://pubmed.ncbi.nlm.nih.gov/35210403
304.Light, J.K., et al. Use of the artificial urinary sphincter in spinal cord injury patients. J Urol, 1983. 130: 1127.
https://pubmed.ncbi.nlm.nih.gov/6644893
305.Farag, F., et al. Surgical treatment of neurogenic stress urinary incontinence: A systematic review of quality assessment and surgical outcomes. Neurourol Urodyn, 2016. 35: 21.
https://pubmed.ncbi.nlm.nih.gov/25327633
306.Kim, S.P., et al. Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan. J Urol, 2008. 179: 1912.
https://pubmed.ncbi.nlm.nih.gov/18353376
307.Wang, R., et al. Long-term outcomes after primary failures of artificial urinary sphincter implantation. Urology, 2012. 79: 922.
https://pubmed.ncbi.nlm.nih.gov/22305763
308.Guillot-Tantay, C., et al. [Male neurogenic stress urinary incontinence treated by artificial urinary sphincter AMS 800 (Boston Scientific, Boston, USA): Very long-term results (>25 years)]. Prog Urol, 2018. 28: 39.
https://pubmed.ncbi.nlm.nih.gov/29102375
309.Phe, V., et al. Stress urinary incontinence in female neurological patients: long-term functional outcomes after artificial urinary sphincter (AMS 800(TM) ) implantation. Neurourol Urodyn, 2017. 36: 764.
https://pubmed.ncbi.nlm.nih.gov/27080729
310.Chartier-Kastler, E., et al. Outcomes of robot-assisted urinary sphincter implantation for male neurogenic urinary incontinence. BJU Int, 2022. 129: 243.
https://pubmed.ncbi.nlm.nih.gov/34174147
311.Scott, K.A., et al. Use of Artificial Urinary Sphincter and Slings to Manage Neurogenic Bladder Following Spinal Cord Injury-Is It Safe? Current Bladder Dysfunction Reports 2017. 12: 311.
https://doi.org/10.1007/s11884-017-0449-9
312.Tricard, T., et al. Outcomes of artificial urinary sphincter in female with neurological stress urinary incontinence: a long-term follow-up. World J Urol, 2021. 39: 157.
https://pubmed.ncbi.nlm.nih.gov/32052128
313.Gasmi, A., et al. Long-term outcomes of artificial urinary sphincter in female patients with spina bifida. Neurourol Urodyn, 2021. 40: 412.
https://pubmed.ncbi.nlm.nih.gov/33197064
314.Ruggiero, M., et al. Single center experience and long-term outcomes of implantable devices ACT and Pro-ACT (Uromedica, Irvin, CA, USA) - Adjustable continence Therapy for treatment of stress urinary incontinence. Prog Urol, 2023. 33: 96.
https://pubmed.ncbi.nlm.nih.gov/36572628
315.Demeestere, A., et al. Adjustable continence therapy (ACT(R)) balloons to treat neurogenic and non-neurogenic female urinary incontinence. Neurourol Urodyn, 2022. 41: 313.
https://pubmed.ncbi.nlm.nih.gov/34633672
316.Ronzi, Y., et al. Neurogenic stress urinary incontinence: is there a place for Adjustable Continence Therapy (ACT and ProACT, Uromedica, Plymouth, MN, USA)? A retrospective multicenter study. Spinal Cord, 2019. 57: 388.
https://pubmed.ncbi.nlm.nih.gov/30626977
317.Donnahoo, K.K., et al. The Young-Dees-Leadbetter bladder neck repair for neurogenic incontinence. J Urol, 1999. 161: 1946.
https://pubmed.ncbi.nlm.nih.gov/10332478
318.Kropp, K.A., et al. Urethral lengthening and reimplantation for neurogenic incontinence in children. J Urol, 1986. 135: 533.
https://pubmed.ncbi.nlm.nih.gov/3944902
319.Salle, J.L., et al. Urethral lengthening with anterior bladder wall flap (Pippi Salle procedure): modifications and extended indications of the technique. J Urol, 1997. 158: 585.
https://pubmed.ncbi.nlm.nih.gov/9224369
320.Rawashdeh, Y.F., et al. International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn, 2012. 31: 615.
https://pubmed.ncbi.nlm.nih.gov/22532368
321.Noordhoff, T.C., et al. Surgical Management of Anatomic Bladder Outlet Obstruction in Males with Neurogenic Bladder Dysfunction: A Systematic Review. Eur Urol Focus, 2019. 5: 875.
https://pubmed.ncbi.nlm.nih.gov/29551557
322.Roth, B., et al. Benign prostatic obstruction and parkinson’s disease--should transurethral resection of the prostate be avoided? J Urol, 2009. 181: 2209.
https://pubmed.ncbi.nlm.nih.gov/19296974
323.Chang, T.L., et al. Surgical outcome of male patients with chronic central nervous system disorders and voiding dysfunction due to bladder outlet obstruction. Int Urol Nephrol, 2022. 54: 2511.
https://pubmed.ncbi.nlm.nih.gov/35821368
324.Cornejo-Davila, V., et al. Incidence of Urethral Stricture in Patients With Spinal Cord Injury Treated With Clean Intermittent Self-Catheterization. Urology, 2017. 99: 260.
https://pubmed.ncbi.nlm.nih.gov/27566143
325.Perkash, I. Ablation of urethral strictures using contact chisel crystal firing neodymium:YAG laser. J Urol, 1997. 157: 809.
https://pubmed.ncbi.nlm.nih.gov/9072572
326.Gonzalez-Espinosa, C., et al. Diagnosis and treatment of urethral stricture in men with neurogenic lower urinary tract dysfunction: A systematic review. Neurourol Urodyn, 2022. 41: 1248.
https://pubmed.ncbi.nlm.nih.gov/35686544
327.Schurch, B., et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol, 2005. 174: 196.
https://pubmed.ncbi.nlm.nih.gov/15947626
328.Madersbacher, H., et al. Twelve o’clock sphincterotomy: technique, indications, results. (Abbreviated report). Urol Int, 1975. 30: 75.
https://pubmed.ncbi.nlm.nih.gov/1118951
329.Perkash, I. Laser sphincterotomy and ablation of the prostate using a sapphire chisel contact tip firing neodymium:YAG laser. J Urol, 1994. 152: 2020.
https://pubmed.ncbi.nlm.nih.gov/7966667
330.Noll, F., et al. Transurethral sphincterotomy in quadriplegic patients: long-term-follow-up. Neurourol Urodyn, 1995. 14: 351.
https://pubmed.ncbi.nlm.nih.gov/7581471
331.Chancellor, M.B., et al. Prospective comparison of external sphincter balloon dilatation and prosthesis placement with external sphincterotomy in spinal cord injured men. Arch Phys Med Rehabil, 1994. 75: 297.
https://pubmed.ncbi.nlm.nih.gov/8129583
332.Derry, F., et al. Audit of bladder neck resection in spinal cord injured patients. Spinal Cord, 1998. 36: 345.
https://pubmed.ncbi.nlm.nih.gov/9601115
333.Chancellor, M.B., et al. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol, 1999. 161: 1545.
https://pubmed.ncbi.nlm.nih.gov/10210393
334.Seoane-Rodriguez, S., et al. Long-term follow-up study of intraurethral stents in spinal cord injured patients with detrusor-sphincter dyssynergia. Spinal Cord, 2007. 45: 621.
https://pubmed.ncbi.nlm.nih.gov/17211463
335.Gajewski, J.B., et al. Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol, 2000. 163: 773.
https://pubmed.ncbi.nlm.nih.gov/10687974
336.Wilson, T.S., et al. UroLume stents: lessons learned. J Urol, 2002. 167: 2477.
https://pubmed.ncbi.nlm.nih.gov/11992061
337.Abdul-Rahman, A., et al. A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury. BJU Int, 2010. 106: 1510.
https://pubmed.ncbi.nlm.nih.gov/20500511
338.Pannek, J., et al. Clinical usefulness of the memokath stent as a second-line procedure after sphincterotomy failure. J Endourol, 2011. 25: 335.
https://pubmed.ncbi.nlm.nih.gov/20977372
339.Polguer, T., et al. [Treatment of detrusor-striated sphincter dyssynergia with permanent nitinol urethral stent: results after a minimum follow-up of 2 years]. Prog Urol, 2012. 22: 1058.
https://pubmed.ncbi.nlm.nih.gov/23182120
340.van der Merwe, A., et al. Outcome of dual flange metallic urethral stents in the treatment of neuropathic bladder dysfunction after spinal cord injury. J Endourol, 2012. 26: 1210.
https://pubmed.ncbi.nlm.nih.gov/22519741
341.Brindley, G.S. An implant to empty the bladder or close the urethra. J Neurol Neurosurg Psychiatry, 1977. 40: 358.
https://pubmed.ncbi.nlm.nih.gov/406364
342.Krasmik, D., et al. Urodynamic results, clinical efficacy, and complication rates of sacral intradural deafferentation and sacral anterior root stimulation in patients with neurogenic lower urinary tract dysfunction resulting from complete spinal cord injury. Neurourol Urodyn, 2014. 33: 1202.
https://pubmed.ncbi.nlm.nih.gov/24038405
343.Benard, A., et al. Comparative cost-effectiveness analysis of sacral anterior root stimulation for rehabilitation of bladder dysfunction in spinal cord injured patients. Neurosurgery, 2013. 73: 600.
https://pubmed.ncbi.nlm.nih.gov/23787880
344.Martens, F.M., et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn, 2011. 30: 551.
https://pubmed.ncbi.nlm.nih.gov/21328472
345.Guiho, T., et al. Sacral Anterior Root Stimulation and Visceral Function Outcomes in Spinal Cord Injury-A Systematic Review of the Literature Over Four Decades. World Neurosurg, 2022. 157: 218.
https://pubmed.ncbi.nlm.nih.gov/34547528
346.Krebs, J., et al. Long-term course of sacral anterior root stimulation in spinal cord injured individuals: The fate of the detrusor. Neurourol Urodyn, 2017. 36: 1596.
https://pubmed.ncbi.nlm.nih.gov/27778371
347.Krebs, J., et al. Charcot arthropathy of the spine in spinal cord injured individuals with sacral deafferentation and anterior root stimulator implantation. Neurourol Urodyn, 2016. 35: 241.
https://pubmed.ncbi.nlm.nih.gov/25524388
348.Nagib, A., et al. Successful control of selective anterior sacral rhizotomy for treatment of spastic bladder and ureteric reflux in paraplegics. Med Serv J Can, 1966. 22: 576.
https://pubmed.ncbi.nlm.nih.gov/5966992
349.Schneidau, T., et al. Selective sacral rhizotomy for the management of neurogenic bladders in spina bifida patients: long-term followup. J Urol, 1995. 154: 766.
https://pubmed.ncbi.nlm.nih.gov/7609174
350.Young, B., et al. Percutaneous sacral rhizotomy for neurogenic detrusor hyperreflexia. J Neurosurg, 1980. 53: 85.
https://pubmed.ncbi.nlm.nih.gov/7411212
351.Koldewijn, E.L., et al. Bladder compliance after posterior sacral root rhizotomies and anterior sacral root stimulation. J Urol, 1994. 151: 955.
https://pubmed.ncbi.nlm.nih.gov/8126835
352.Singh, G., et al. Intravesical oxybutynin in patients with posterior rhizotomies and sacral anterior root stimulators. Neurourol Urodyn, 1995. 14: 65.
https://pubmed.ncbi.nlm.nih.gov/7742851
353.Van Kerrebroeck, P.E., et al. Results of the treatment of neurogenic bladder dysfunction in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation. J Urol, 1996. 155: 1378.
https://pubmed.ncbi.nlm.nih.gov/8632580
354.Kutzenberger, J. Surgical therapy of neurogenic detrusor overactivity (hyperreflexia) in paraplegic patients by sacral deafferentation and implant driven micturition by sacral anterior root stimulation: methods, indications, results, complications, and future prospects. Acta Neurochir Suppl, 2007. 97: 333.
https://pubmed.ncbi.nlm.nih.gov/17691394
355.Bhadra, N., et al. Selective suppression of sphincter activation during sacral anterior nerve root stimulation. Neurourol Urodyn, 2002. 21: 55.
https://pubmed.ncbi.nlm.nih.gov/11835425
356.Kirkham, A.P., et al. Neuromodulation through sacral nerve roots 2 to 4 with a Finetech-Brindley sacral posterior and anterior root stimulator. Spinal Cord, 2002. 40: 272.
https://pubmed.ncbi.nlm.nih.gov/12037708
357.Schumacher, S., et al. Extradural cold block for selective neurostimulation of the bladder: development of a new technique. J Urol, 1999. 161: 950.
https://pubmed.ncbi.nlm.nih.gov/10022732
358.Liechti, M.D., et al. Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction. NEJM Evidence, 2022. 1: EVIDoa2200071.
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200071
359.Greenberg, D.R., et al. Sacral Nerve Stimulation in Parkinson’s Disease Patients With Overactive Bladder Symptoms. Urology, 2020. 144: 99.
https://pubmed.ncbi.nlm.nih.gov/32681915
360.Kessler, T.M., et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol, 2010. 58: 865.
https://pubmed.ncbi.nlm.nih.gov/20934242
361.van Ophoven, A., et al. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years’ Experience and Future Directions. Adv Ther, 2021. 38: 1987.
https://pubmed.ncbi.nlm.nih.gov/33713279
362.Guitynavard, F., et al. Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Mult Scler Relat Disord, 2022. 58: 103392.
https://pubmed.ncbi.nlm.nih.gov/35216773
363.Pericolini, M., et al. Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review. Neuromodulation, 2022. 25: 1065.
https://pubmed.ncbi.nlm.nih.gov/34496454
364.Pattanshetti, S., et al. Transcutaneous Electrical Nerve Stimulation in Management of Neurogenic bladder Secondary to Spina Bifida. J Indian Assoc Pediatr Surg, 2022. 27: 570.
https://pubmed.ncbi.nlm.nih.gov/36530811
365.Jorg, E., et al. Deep brain stimulation effects on lower urinary tract function: Systematic review and meta-analysis. Parkinsonism Relat Disord, 2020. 79: 65.
https://pubmed.ncbi.nlm.nih.gov/32889502
366.Sartori, A.M., et al. Effects of Deep Brain Stimulation on Lower Urinary Tract Function in Neurological Patients. Eur Urol Focus, 2022. 8: 1775.
https://pubmed.ncbi.nlm.nih.gov/35662503
367.Zhang, Y.H., et al. Enveloping the bladder with displacement of flap of the rectus abdominis muscle for the treatment of neurogenic bladder. J Urol, 1990. 144: 1194.
https://pubmed.ncbi.nlm.nih.gov/2146404
368.Stenzl, A., et al. Restoration of voluntary emptying of the bladder by transplantation of innervated free skeletal muscle. Lancet, 1998. 351: 1483.
https://pubmed.ncbi.nlm.nih.gov/9605805
369.Gakis, G., et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol, 2011. 185: 593.
https://pubmed.ncbi.nlm.nih.gov/21168866
370.Ninkovic, M., et al. The latissimus dorsi detrusor myoplasty for functional treatment of bladder acontractility. Clin Plast Surg, 2012. 39: 507.
https://pubmed.ncbi.nlm.nih.gov/23036300
371.Duel, B.P., et al. Alternative techniques for augmentation cystoplasty. J Urol, 1998. 159: 998.
https://pubmed.ncbi.nlm.nih.gov/9474216
372.Snow, B.W., et al. Bladder autoaugmentation. Urol Clin North Am, 1996. 23: 323.
https://pubmed.ncbi.nlm.nih.gov/8659030
373.Stohrer, M., et al. Bladder auto-augmentation--an alternative for enterocystoplasty: preliminary results. Neurourol Urodyn, 1995. 14: 11.
https://pubmed.ncbi.nlm.nih.gov/7742844
374.Stohrer, M., et al. Bladder autoaugmentation in adult patients with neurogenic voiding dysfunction. Spinal Cord, 1997. 35: 456.
https://pubmed.ncbi.nlm.nih.gov/9232751
375.Vainrib, M., et al. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Neurourol Urodyn, 2013. 32: 250.
https://pubmed.ncbi.nlm.nih.gov/22965686
376.Krebs, J., et al. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. Neurourol Urodyn, 2016. 35: 260.
https://pubmed.ncbi.nlm.nih.gov/25524480
377.‘t Hoen, L., et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review. Neurourol Urodyn, 2017. 36: 1685.
https://pubmed.ncbi.nlm.nih.gov/28169459
378.Trojan, K.C., et al. Improvement of bladder function after bladder augmentation surgery: a report of 26 years of clinical experience. Pediatr Surg Int, 2022. 38: 941.
https://pubmed.ncbi.nlm.nih.gov/35348841
379.Romero-Maroto, J., et al. Long-term effectiveness and safety of bladder augmentation in spina bifida patients. Neurourol Urodyn, 2021. 40: 1576.
https://pubmed.ncbi.nlm.nih.gov/34082472
380.Wang, Z., et al. Effectiveness and Complications of Augmentation Cystoplasty with or without Nonrefluxing Ureteral Reimplantation in Patients with Bladder Dysfunction: A Single Center 11-Year Experience. Journal of Urology, 2018. 199: 200.
https://pubmed.ncbi.nlm.nih.gov/28743527
381.Myers, J.B., et al. The effects of augmentation cystoplasty and botulinum toxin injection on patient-reported bladder function and quality of life among individuals with spinal cord injury performing clean intermittent catheterization. Neurourol Urodyn, 2019. 38: 285.
https://pubmed.ncbi.nlm.nih.gov/30375055
382.Mitsui, T., et al. Preoperative renal scar as a risk factor of postoperative metabolic acidosis following ileocystoplasty in patients with neurogenic bladder. Spinal Cord, 2014. 52: 292.
https://pubmed.ncbi.nlm.nih.gov/24469144
383.Balanca, A., et al. Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury. World J Urol, 2022. 40: 2121.
https://pubmed.ncbi.nlm.nih.gov/35680652
384.Perrouin-Verbe, M.A., et al. Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: A single-center experience in a multidisciplinary team. Neurourol Urodyn, 2019. 38: 330.
https://pubmed.ncbi.nlm.nih.gov/30350892
385.Frainey, B.T., et al. Complications of Pediatric Bladder Reconstruction in the Adult Patient. Current Bladder Dysfunction Reports, 2020. 15: 173.
https://doi.org/10.1007/s11884-020-00584-2
386.Moreno, J.G., et al. Improved quality of life and sexuality with continent urinary diversion in quadriplegic women with umbilical stoma. Arch Phys Med Rehabil, 1995. 76: 758.
https://pubmed.ncbi.nlm.nih.gov/7632132
387.Peterson, A.C., et al. Urinary diversion in patients with spinal cord injury in the United States. Urology, 2012. 80: 1247.
https://pubmed.ncbi.nlm.nih.gov/23206770
388.Sylora, J.A., et al. Intermittent self-catheterization by quadriplegic patients via a catheterizable Mitrofanoff channel. J Urol, 1997. 157: 48.
https://pubmed.ncbi.nlm.nih.gov/8976213
389.Van Savage, J.G., et al. Transverse retubularized sigmoidovesicostomy continent urinary diversion to the umbilicus. J Urol, 2001. 166: 644.
https://pubmed.ncbi.nlm.nih.gov/11458110
390.Vanni, A.J., et al. Ileovesicostomy for the neurogenic bladder patient: outcome and cost comparison of open and robotic assisted techniques. Urology, 2011. 77: 1375.
https://pubmed.ncbi.nlm.nih.gov/21146864
391.Wiener, J.S., et al. Bladder augmentation versus urinary diversion in patients with spina bifida in the United States. J Urol, 2011. 186: 161.
https://pubmed.ncbi.nlm.nih.gov/21575969
392.Cheng, P.J., et al. Contemporary multicenter outcomes of continent cutaneous ileocecocystoplasty in the adult population over a 10-year period: A Neurogenic Bladder Research Group study. Neurourol Urodyn, 2020. 39: 1771.
https://pubmed.ncbi.nlm.nih.gov/32506711
393.Phe, V., et al. Continent catheterizable tubes/stomas in adult neuro-urological patients: A systematic review. Neurourol Urodyn, 2017. 36: 1711.
https://pubmed.ncbi.nlm.nih.gov/28139848
394.Gharbi, M., et al. Quality of life in neurogenic patients based on different bladder management methods: A review. Prog Urol, 2022. 32: 784.
https://pubmed.ncbi.nlm.nih.gov/35941011
395.Atan, A., et al. Advantages and risks of ileovesicostomy for the management of neuropathic bladder. Urology, 1999. 54: 636.
https://pubmed.ncbi.nlm.nih.gov/10510920
396.Cass, A.S., et al. A 22-Year Followup of Ileal Conduits in Children with a Neurogenic Bladder. Journal of Urology, 1984. 132: 529.
https://pubmed.ncbi.nlm.nih.gov/6471190
397.Hald, T., et al. Vesicostomy--an alternative urine diversion operation. Long term results. Scand J Urol Nephrol, 1978. 12: 227.
https://pubmed.ncbi.nlm.nih.gov/725543
398.Schwartz, S.L., et al. Incontinent ileo-vesicostomy urinary diversion in the treatment of lower urinary tract dysfunction. J Urol, 1994. 152: 99.
https://pubmed.ncbi.nlm.nih.gov/8201699
399.Sakhri, R., et al. [Laparoscopic cystectomy and ileal conduit urinary diversion for neurogenic bladders and related conditions. Morbidity and better quality of life]. Prog Urol, 2015. 25: 342.
https://pubmed.ncbi.nlm.nih.gov/25726693
400.Akakpo, W., et al. Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis. Neurourol Urodyn, 2020. 39: 771.
https://pubmed.ncbi.nlm.nih.gov/31951678
401.Mazouin, C., et al. Robot-Assisted Cystectomy and Ileal Conduit for Neurogenic Bladder: Comparison of Extracorporeal vs Intracorporeal Urinary Diversion. J Endourol, 2021. 35: 1350.
https://pubmed.ncbi.nlm.nih.gov/33499755
402.Haudebert, C., et al. Cystectomy and ileal conduit for neurogenic bladder: Comparison of the open, laparoscopic and robotic approaches. Neurourol Urodyn, 2022. 41: 601.
https://pubmed.ncbi.nlm.nih.gov/34962653
403.Chkir, S., et al. Non-continent Urinary Diversion (Ileal Conduit) as Salvage Therapy in Patients With Refractory Lower Urinary Tract Dysfunctions due to Multiple Sclerosis: Results of a National Cohort From the French Association of Urology (AFU) Neurourology Committee and the French-speaking Neurourology Study Group (GENULF). Urology, 2022. 168: 216.
https://pubmed.ncbi.nlm.nih.gov/35768028
404.Beirnaert, J., et al. Robotic versus open cystectomy with ileal conduit for the management of neurogenic bladder: a comparative study. World J Urol, 2022. 40: 2963.
https://pubmed.ncbi.nlm.nih.gov/36280600
405.Herschorn, S., et al. Urinary undiversion in adults with myelodysplasia: long-term followup. J Urol, 1994. 152: 329.
https://pubmed.ncbi.nlm.nih.gov/8015064
406.Sartori, A.M., et al. Definitions of Urinary Tract Infection Used in Interventional Studies Involving Neurourological Patients-A Systematic Review. Eur Urol Focus, 2022. 8: 1386.
https://pubmed.ncbi.nlm.nih.gov/34404618
407.Mukai, S., et al. Retrospective study for risk factors for febrile UTI in spinal cord injury patients with routine concomitant intermittent catheterization in outpatient settings. Spinal Cord, 2016. 54: 69.
https://pubmed.ncbi.nlm.nih.gov/26458969
408.Everett, R.G., et al. Factors associated with recurrent urinary tract infections in spinal cord injured patients who use intermittent catheterization. Can J Urol, 2021. 28: 10920.
https://pubmed.ncbi.nlm.nih.gov/34895397
409.Vasudeva, P., et al. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn, 2014. 33: 95.
https://pubmed.ncbi.nlm.nih.gov/23460489
410.Ruijuan, Z., et al. Effects of Catheter Tracking Management on Urinary Tract Function and Infection Rates in Patients With Spinal Cord Injury. Altern Ther Health Med, 2023. 29: 104.
https://pubmed.ncbi.nlm.nih.gov/36634314
411.Welk, B., et al. Differences in the incidence of urinary tract infections between neurogenic and non-neurogenic bladder dysfunction individuals performing intermittent catheterization. Neurourol Urodyn, 2022. 41: 1002.
https://pubmed.ncbi.nlm.nih.gov/35332597
412.Zhou, L., et al. Early warning model construction and validation for urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD): a retrospective study. PeerJ, 2022. 10: e13388.
https://pubmed.ncbi.nlm.nih.gov/35539015
413.Lenherr, S.M., et al. Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC. J Urol, 2016. 196: 1129.
https://pubmed.ncbi.nlm.nih.gov/27131462
414.Bakke, A., et al. Bacteriuria in patients treated with clean intermittent catheterization. Scand J Infect Dis, 1991. 23: 577.
https://pubmed.ncbi.nlm.nih.gov/1767253
415.Waites, K.B., et al. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil, 1993. 74: 691.
https://pubmed.ncbi.nlm.nih.gov/8328888
416.Nicolle, L.E., et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis, 2005. 40: 643.
https://pubmed.ncbi.nlm.nih.gov/15714408
417.Wang, W., et al. A risk prediction model of urinary tract infections for patients with neurogenic bladder. Int J Neurosci, 2021. 131: 31.
https://pubmed.ncbi.nlm.nih.gov/32075472
418.Wirth, M., et al. Retrospective Cohort Study of Patient-Reported Urinary Tract Infection Signs and Symptoms Among Individuals With Neurogenic Bladder. Am J Phys Med Rehabil, 2023. 102: 663.
https://pubmed.ncbi.nlm.nih.gov/36927768
419.Pannek, J. Treatment of urinary tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. A questionnaire-based survey and review of the literature. J Spinal Cord Med, 2011. 34: 11.
https://pubmed.ncbi.nlm.nih.gov/21528621
420.Alavinia, S.M., et al. Enhancing quality practice for prevention and diagnosis of urinary tract infection during inpatient spinal cord rehabilitation. J Spinal Cord Med, 2017. 40: 803.
https://pubmed.ncbi.nlm.nih.gov/28872426
421.Deville, W.L., et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol, 2004. 4: 4.
https://pubmed.ncbi.nlm.nih.gov/15175113
422.Hoffman, J.M., et al. Nitrite and leukocyte dipstick testing for urinary tract infection in individuals with spinal cord injury. J Spinal Cord Med, 2004. 27: 128.
https://pubmed.ncbi.nlm.nih.gov/15162883
423.Biering-Sorensen, F., et al. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs, 2001. 61: 1275.
https://pubmed.ncbi.nlm.nih.gov/11511022
424.Everaert, K., et al. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg, 2009. 64: 335.
https://pubmed.ncbi.nlm.nih.gov/19810421
425.Clark, R., et al. The ability of prior urinary cultures results to predict future culture results in neurogenic bladder patients. Neurourol Urodyn, 2018. 37: 2645.
https://pubmed.ncbi.nlm.nih.gov/29799144
426.Pannek, J., et al. Treatment of Complicated Urinary Tract Infections in Individuals with Chronic Neurogenic Lower Urinary Tract Dysfunction: Are Antibiotics Mandatory? Urol Int, 2018. 100: 434.
https://pubmed.ncbi.nlm.nih.gov/29649808
427.Del Popolo, G., et al. Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment. Arch Ital Urol Androl, 2018. 90: 101.
https://pubmed.ncbi.nlm.nih.gov/29974728
428.Jia, C., et al. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord, 2013. 51: 487.
https://pubmed.ncbi.nlm.nih.gov/23357928
429.Gallien, P., et al. Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial. Mult Scler, 2014. 20: 1252.
https://pubmed.ncbi.nlm.nih.gov/24402038
430.Toh, S.L., et al. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial. Spinal Cord, 2019. 57: 550.
https://pubmed.ncbi.nlm.nih.gov/30814670
431.Lee, B.S., et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev, 2012. 10: CD003265.
https://pubmed.ncbi.nlm.nih.gov/23076896
432.Günther, M., et al. Harnwegsinfektprophylaxe. Urinansäuerung mittels L-Methionin bei neurogener Blasenfunktionsstörung. Urologe B, 2002. 42: 218.
https://link.springer.com/article/10.1007/s00131-002-0207-x
433.Hachen, H.J. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial. J Urol, 1990. 143: 759.
https://pubmed.ncbi.nlm.nih.gov/2179584
434.Krebs, J., et al. Effects of oral immunomodulation therapy on urinary tract infections in individuals with chronic spinal cord injury-A retrospective cohort study. Neurourol Urodyn, 2019. 38: 346.
https://pubmed.ncbi.nlm.nih.gov/30350886
435.Welk, B., et al. Efficacy of antibiotic prophylaxis among intermittent catheter users with different neurologic diseases: A secondary analysis of the AnTIC Trial. Continence, 2022. 1: 100004.
https://doi.org/10.1016/j.cont.2022.100004
436.Poirier, C., et al. Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria. Med Mal Infect, 2016. 46: 294.
https://pubmed.ncbi.nlm.nih.gov/27321478
437.Darouiche, R.O., et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology, 2011. 78: 341.
https://pubmed.ncbi.nlm.nih.gov/21683991
438.Pannek, J., et al. Usefulness of classical homeopathy for the prophylaxis of recurrent urinary tract infections in individuals with chronic neurogenic lower urinary tract dysfunction. J Spinal Cord Med, 2019. 42: 453.
https://pubmed.ncbi.nlm.nih.gov/29485355
439.Moussa, M., et al. Bladder irrigation with povidone-iodine prevent recurrent urinary tract infections in neurogenic bladder patients on clean intermittent catheterization. Neurourol Urodyn, 2021. 40: 672.
https://pubmed.ncbi.nlm.nih.gov/33476092
440.Cox, L., et al. Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization. Can Urol Assoc J, 2017. 11: E350.
https://pubmed.ncbi.nlm.nih.gov/29382457
441.Ziadeh, T., et al. Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review. Urologia, 2022. 89: 261.
https://pubmed.ncbi.nlm.nih.gov/34612750
442.Pannek, J., et al. Usefulness of classical homoeopathy for the prevention of urinary tract infections in patients with neurogenic bladder dysfunction: A case series. . Indian J Res Homoeopathy, 2014. 8: 31.
https://www.ijrh.org/journal/vol8/iss1/6/
443.Rees, P.M., et al. Sexual function in men and women with neurological disorders. Lancet, 2007. 369: 512.
https://pubmed.ncbi.nlm.nih.gov/17292771
444.Lombardi, G., et al. Management of sexual dysfunction due to central nervous system disorders: a systematic review. BJU Int, 2015. 115 Suppl 6: 47.
https://pubmed.ncbi.nlm.nih.gov/25599613
445.Salonia, A., et al., EAU Guidelines on sexual and reproductive health, in EAU Guidelines. Edn. presented at the EAU Annual Congress Milan. March 2023.
446.Hentzen, C., et al. Approach and management to patients with neurological disorders reporting sexual dysfunction. Lancet Neurol, 2022. 21: 551.
https://pubmed.ncbi.nlm.nih.gov/35405093
447.Foley, F.W., Sexuality, in Multiple Sclerosis: A Guide for Families K. RC., Editor. 2006, Demos Medical Publishing: New York, USA.
448.Annon, J.S., PLISSIT Therapy in Handbook of Innovative Psychotherapies. , R. Corsini, Editor. 1981, Wiley & Sons: New York.
449.Fragala, E., et al. Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction. Eur J Neurol, 2015. 22: 485.
https://pubmed.ncbi.nlm.nih.gov/25410608
450.Game, X., et al. Sexual function of young women with myelomeningocele. J Pediatr Urol, 2014. 10: 418.
https://pubmed.ncbi.nlm.nih.gov/23992838
451.Chen, L., et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol, 2015. 68: 674.
https://pubmed.ncbi.nlm.nih.gov/25817916
452.Fowler, C.J., et al. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry, 2005. 76: 700.
https://pubmed.ncbi.nlm.nih.gov/15834030
453.Safarinejad, M.R. Expression of Concern: Evaluation of the Safety and Efficacy of Sildenafil Citrate for Erectile Dysfunction in Men With Multiple Sclerosis: A Double-Blind, Placebo Controlled, Randomized Study. J Urol, 2023: 101097JU0000000000003114.
https://pubmed.ncbi.nlm.nih.gov/36626341
454.Streur, C.S., et al. Sexual Function of Men and Women With Spina Bifida: A Scoping Literature Review. Sex Med Rev, 2021. 9: 244.
https://pubmed.ncbi.nlm.nih.gov/33608247
455.Lombardi, G., et al. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. J Sex Med, 2009. 6: 1248.
https://pubmed.ncbi.nlm.nih.gov/19210710
456.Lombardi, G., et al. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med, 2012. 9: 970.
https://pubmed.ncbi.nlm.nih.gov/22304626
457.Cardenas, D.D., et al. Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury. Spinal Cord, 2014. 52: 70.
https://pubmed.ncbi.nlm.nih.gov/24216616
458.Strebel, R.T., et al. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury. BJU Int, 2004. 93: 100.
https://pubmed.ncbi.nlm.nih.gov/14678378
459.Pohanka, M., et al. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson’s disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Parkinsonism Relat Disord, 2005. 11: 509.
https://pubmed.ncbi.nlm.nih.gov/15994112
460.Chancellor, M.B., et al. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury. Urology, 1994. 43: 365.
https://pubmed.ncbi.nlm.nih.gov/8134992
461.Cookson, M.S., et al. Long-term results with vacuum constriction device. J Urol, 1993. 149: 290.
https://pubmed.ncbi.nlm.nih.gov/8426404
462.Denil, J., et al. Vacuum erection device in spinal cord injured men: patient and partner satisfaction. Arch Phys Med Rehabil, 1996. 77: 750.
https://pubmed.ncbi.nlm.nih.gov/8702367
463.Levine, L.A. External devices for treatment of erectile dysfunction. Endocrine, 2004. 23: 157.
https://pubmed.ncbi.nlm.nih.gov/15146095
464.Levine, L.A., et al. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am, 2001. 28: 335.
https://pubmed.ncbi.nlm.nih.gov/11402585
465.Bella, A.J., et al. Intracavernous pharmacotherapy for erectile dysfunction. Endocrine, 2004. 23: 149.
https://pubmed.ncbi.nlm.nih.gov/15146094
466.Bodner, D.R., et al. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. J Urol, 1987. 138: 310.
https://pubmed.ncbi.nlm.nih.gov/3599245
467.Deforge, D., et al. Male erectile dysfunction following spinal cord injury: a systematic review. Spinal Cord, 2006. 44: 465.
https://pubmed.ncbi.nlm.nih.gov/16317419
468.Dinsmore, W.W., et al. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study. BJU Int, 1999. 83: 274.
https://pubmed.ncbi.nlm.nih.gov/10233493
469.Hirsch, I.H., et al. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia, 1994. 32: 661.
https://pubmed.ncbi.nlm.nih.gov/7831071
470.Kapoor, V.K., et al. Intracavernous papaverine for impotence in spinal cord injured patients. Paraplegia, 1993. 31: 675.
https://pubmed.ncbi.nlm.nih.gov/8259331
471.Vidal, J., et al. Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients. Rev Neurol, 1995. 23: 269.
https://pubmed.ncbi.nlm.nih.gov/7497173
472.Bodner, D.R., et al. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology, 1999. 53: 199.
https://pubmed.ncbi.nlm.nih.gov/9886612
473.Gross, A.J., et al. Penile prostheses in paraplegic men. Br J Urol, 1996. 78: 262.
https://pubmed.ncbi.nlm.nih.gov/8813925
474.Kimoto, Y., et al. Penile prostheses for the management of the neuropathic bladder and sexual dysfunction in spinal cord injury patients: long term follow up. Paraplegia, 1994. 32: 336.
https://pubmed.ncbi.nlm.nih.gov/8058351
475.Zermann, D.H., et al. Penile prosthetic surgery in neurologically impaired patients: long-term followup. J Urol, 2006. 175: 1041.
https://pubmed.ncbi.nlm.nih.gov/16469612
476.Fode, M., et al. Male sexual dysfunction and infertility associated with neurological disorders. Asian J Androl, 2012. 14: 61.
https://pubmed.ncbi.nlm.nih.gov/22138899
477.Lim, T.C., et al. A simple technique to prevent retrograde ejaculation during assisted ejaculation. Paraplegia, 1994. 32: 142.
https://pubmed.ncbi.nlm.nih.gov/8008416
478.Philippon, M., et al. Successful pregnancies and healthy live births using frozen-thawed sperm retrieved by a new modified Hotchkiss procedure in males with retrograde ejaculation: first case series. Basic Clin Androl, 2015. 25: 5.
https://pubmed.ncbi.nlm.nih.gov/26034605
479.Arafa, M.M., et al. Prostatic massage: a simple method of semen retrieval in men with spinal cord injury. Int J Androl, 2007. 30: 170.
https://pubmed.ncbi.nlm.nih.gov/17298549
480.Kolettis, P.N., et al. Fertility outcomes after electroejaculation in men with spinal cord injury. Fertil Steril, 2002. 78: 429.
https://pubmed.ncbi.nlm.nih.gov/12137889
481.Chehensse, C., et al. The spinal control of ejaculation revisited: a systematic review and meta-analysis of anejaculation in spinal cord injured patients. Hum Reprod Update, 2013. 19: 507.
https://pubmed.ncbi.nlm.nih.gov/23820516
482.Beretta, G., et al. Reproductive aspects in spinal cord injured males. Paraplegia, 1989. 27: 113.
https://pubmed.ncbi.nlm.nih.gov/2717193
483.Brackett, N.L., et al. Application of 2 vibrators salvages ejaculatory failures to 1 vibrator during penile vibratory stimulation in men with spinal cord injuries. J Urol, 2007. 177: 660.
https://pubmed.ncbi.nlm.nih.gov/17222653
484.Sonksen, J., et al. Ejaculation induced by penile vibratory stimulation in men with spinal cord injuries. The importance of the vibratory amplitude. Paraplegia, 1994. 32: 651.
https://pubmed.ncbi.nlm.nih.gov/7831070
485.Claydon, V.E., et al. Cardiovascular responses to vibrostimulation for sperm retrieval in men with spinal cord injury. J Spinal Cord Med, 2006. 29: 207.
https://pubmed.ncbi.nlm.nih.gov/16859224
486.Ekland, M.B., et al. Incidence of autonomic dysreflexia and silent autonomic dysreflexia in men with spinal cord injury undergoing sperm retrieval: implications for clinical practice. J Spinal Cord Med, 2008. 31: 33.
https://pubmed.ncbi.nlm.nih.gov/18533409
487.Soler, J.M., et al. Midodrine improves ejaculation in spinal cord injured men. J Urol, 2007. 178: 2082.
https://pubmed.ncbi.nlm.nih.gov/17869290
488.Pecori, C., et al. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol, 2014. 14: 114.
https://pubmed.ncbi.nlm.nih.gov/24884599
489.Brackett, N.L., et al. Treatment of infertility in men with spinal cord injury. Nat Rev Urol, 2010. 7: 162.
https://pubmed.ncbi.nlm.nih.gov/20157304
490.Raviv, G., et al. Testicular sperm retrieval and intra cytoplasmic sperm injection provide favorable outcome in spinal cord injury patients, failing conservative reproductive treatment. Spinal Cord, 2013. 51: 642.
https://pubmed.ncbi.nlm.nih.gov/23689394
491.Schatte, E.C., et al. Treatment of infertility due to anejaculation in the male with electroejaculation and intracytoplasmic sperm injection. J Urol, 2000. 163: 1717.
https://pubmed.ncbi.nlm.nih.gov/10799167
492.Shieh, J.Y., et al. A protocol of electroejaculation and systematic assisted reproductive technology achieved high efficiency and efficacy for pregnancy for anejaculatory men with spinal cord injury. Arch Phys Med Rehabil, 2003. 84: 535.
https://pubmed.ncbi.nlm.nih.gov/12690592
493.Taylor, Z., et al. Contribution of the assisted reproductive technologies to fertility in males suffering spinal cord injury. Aust N Z J Obstet Gynaecol, 1999. 39: 84.
https://pubmed.ncbi.nlm.nih.gov/10099757
494.Rutkowski, S.B., et al. The influence of bladder management on fertility in spinal cord injured males. Spinal Cord, 1995. 33: 263.
https://pubmed.ncbi.nlm.nih.gov/7630651
495.Hamed, S.A., et al. Seminal fluid analysis and testicular volume in adults with epilepsy receiving valproate. J Clin Neurosci, 2015. 22: 508.
https://pubmed.ncbi.nlm.nih.gov/25636832
496.Ohl, D.A., et al. Electroejaculation versus vibratory stimulation in spinal cord injured men: sperm quality and patient preference. J Urol, 1997. 157: 2147.
https://pubmed.ncbi.nlm.nih.gov/9146603
497.Brackett, N.L., et al. Semen quality of spinal cord injured men is better when obtained by vibratory stimulation versus electroejaculation. J Urol, 1997. 157: 151.
https://pubmed.ncbi.nlm.nih.gov/8976239
498.Brackett, N.L., et al. Semen retrieval in men with spinal cord injury is improved by interrupting current delivery during electroejaculation. J Urol, 2002. 167: 201.
https://pubmed.ncbi.nlm.nih.gov/11743305
499.DeForge, D., et al. Fertility following spinal cord injury: a systematic review. Spinal Cord, 2005. 43: 693.
https://pubmed.ncbi.nlm.nih.gov/15951744
500.Ferreiro-Velasco, M.E., et al. Sexual issues in a sample of women with spinal cord injury. Spinal Cord, 2005. 43: 51.
https://pubmed.ncbi.nlm.nih.gov/15303115
501.Kreuter, M., et al. Sexuality and sexual life in women with spinal cord injury: a controlled study. J Rehabil Med, 2008. 40: 61.
https://pubmed.ncbi.nlm.nih.gov/18176739
502.Kreuter, M., et al. Sexual adjustment and quality of relationship in spinal paraplegia: a controlled study. Arch Phys Med Rehabil, 1996. 77: 541.
https://pubmed.ncbi.nlm.nih.gov/8831469
503.Kessler, T.M., et al. Sexual dysfunction in multiple sclerosis. Expert Rev Neurother, 2009. 9: 341.
https://pubmed.ncbi.nlm.nih.gov/19271943
504.Lew-Starowicz, M., et al. Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis. Sex Disabil, 2013. 31: 141.
https://pubmed.ncbi.nlm.nih.gov/23704801
505.Motta, G.L., et al. Sexuality of Female Spina Bifida Patients: Predictors of a Satisfactory Sexual Function. Rev Bras Ginecol Obstet, 2021. 43: 467.
https://pubmed.ncbi.nlm.nih.gov/34318472
506.Motta, G.L., et al. The impact of neurogenic bladder bowel dysfunction in the sexuality of female spina bifida patients. J Pediatr Urol, 2021. 17: 288 e1.
https://pubmed.ncbi.nlm.nih.gov/33546979
507.Alexander, M., et al. Spinal cord injuries and orgasm: a review. J Sex Marital Ther, 2008. 34: 308.
https://pubmed.ncbi.nlm.nih.gov/18576233
508.McAlonan, S. Improving sexual rehabilitation services: the patient’s perspective. Am J Occup Ther, 1996. 50: 826.
https://pubmed.ncbi.nlm.nih.gov/8947375
509.Schopp, L.H., et al. Impact of comprehensive gynecologic services on health maintenance behaviours among women with spinal cord injury. Disabil Rehabil, 2002. 24: 899.
https://pubmed.ncbi.nlm.nih.gov/12519485
510.Vikan, J.K., et al. Sexual Satisfaction and Associated Biopsychosocial Factors in Stroke Patients Admitted to Specialized Cognitive Rehabilitation. Sex Med, 2021. 9: 100424.
https://pubmed.ncbi.nlm.nih.gov/34474266
511.Reitz, A., et al. Impact of spinal cord injury on sexual health and quality of life. Int J Impot Res, 2004. 16: 167.
https://pubmed.ncbi.nlm.nih.gov/14973522
512.Harrison, J., et al. Factors associated with sexual functioning in women following spinal cord injury. Paraplegia, 1995. 33: 687.
https://pubmed.ncbi.nlm.nih.gov/8927405
513.Westgren, N., et al. Sexuality in women with traumatic spinal cord injury. Acta Obstet Gynecol Scand, 1997. 76: 977.
https://pubmed.ncbi.nlm.nih.gov/9435740
514.Fruhauf, S., et al. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav, 2013. 42: 915.
https://pubmed.ncbi.nlm.nih.gov/23559141
515.Sipski, M.L., et al. Physiologic parameters associated with sexual arousal in women with incomplete spinal cord injuries. Arch Phys Med Rehabil, 1997. 78: 305.
https://pubmed.ncbi.nlm.nih.gov/9084355
516.Sipski, M.L., et al. Sexual arousal and orgasm in women: effects of spinal cord injury. Ann Neurol, 2001. 49: 35.
https://pubmed.ncbi.nlm.nih.gov/11198294
517.Sukumaran, S.C., et al. Polytherapy increases the risk of infertility in women with epilepsy. Neurology, 2010. 75: 1351.
https://pubmed.ncbi.nlm.nih.gov/20938026
518.Axel, S.J. Spinal cord injured women’s concerns: menstruation and pregnancy. Rehabil Nurs, 1982. 7: 10.
https://pubmed.ncbi.nlm.nih.gov/6921826
519.Jackson, A.B., et al. A multicenter study of women’s self-reported reproductive health after spinal cord injury. Arch Phys Med Rehabil, 1999. 80: 1420.
https://pubmed.ncbi.nlm.nih.gov/10569436
520.Baker, E.R., et al. Pregnancy in spinal cord injured women. Arch Phys Med Rehabil, 1996. 77: 501.
https://pubmed.ncbi.nlm.nih.gov/8629929
521.Baker, E.R., et al. Risks associated with pregnancy in spinal cord-injured women. Obstet Gynecol, 1992. 80: 425.
https://pubmed.ncbi.nlm.nih.gov/1495699
522.Bertschy, S., et al. Delivering care under uncertainty: Swiss providers’ experiences in caring for women with spinal cord injury during pregnancy and childbirth - an expert interview study. BMC Pregnancy Childbirth, 2016. 16: 181.
https://pubmed.ncbi.nlm.nih.gov/27443838
523.Le Liepvre, H., et al. Pregnancy in spinal cord-injured women, a cohort study of 37 pregnancies in 25 women. Spinal Cord, 2017. 55: 167.
https://pubmed.ncbi.nlm.nih.gov/27670808
524.Skowronski, E., et al. Obstetric management following traumatic tetraplegia: case series and literature review. Aust N Z J Obstet Gynaecol, 2008. 48: 485.
https://pubmed.ncbi.nlm.nih.gov/19032665
525.Cross, L.L., et al. Pregnancy, labor and delivery post spinal cord injury. Paraplegia, 1992. 30: 890.
https://pubmed.ncbi.nlm.nih.gov/1287543
526.Hughes, S.J., et al. Management of the pregnant woman with spinal cord injuries. Br J Obstet Gynaecol, 1991. 98: 513.
https://pubmed.ncbi.nlm.nih.gov/1873238
527.Dannels, A., et al. The perimenopause experience for women with spinal cord injuries. SCI Nurs, 2004. 21: 9.
https://pubmed.ncbi.nlm.nih.gov/15176344
528.Amato, M.P., et al. Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. Neurol Sci, 2017. 38: 1849.
https://pubmed.ncbi.nlm.nih.gov/28770366
529.Delaney, K.E., et al. Multiple sclerosis and sexual dysfunction: A need for further education and interdisciplinary care. NeuroRehabilitation, 2017. 41: 317.
https://pubmed.ncbi.nlm.nih.gov/29036844
530.Kanagaraj, P., et al. Multiple sclerosis and pregnancy. The Obstetrician & Gynaecologist, 2019. 21: 177.
https://obgyn.onlinelibrary.wiley.com/journal/17444667
531.Bove, R., et al. Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol, 2014. 124: 1157.
https://pubmed.ncbi.nlm.nih.gov/25415167
532.Abrams, P., et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int, 2008. 101: 989.
https://pubmed.ncbi.nlm.nih.gov/18279449
533.Ineichen, B.V., et al. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis. Mult Scler, 2018. 24: 529.
https://pubmed.ncbi.nlm.nih.gov/28367674
534.Beck, J., et al. Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis. Diagnostics (Basel), 2022. 12.
https://pubmed.ncbi.nlm.nih.gov/35054358
535.Pannek, J., et al. Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: urodynamics made easy? World J Urol, 2013. 31: 659.
https://pubmed.ncbi.nlm.nih.gov/23073657
536.Silva, J.A., et al. Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury. World J Urol, 2015. 33: 131.
https://pubmed.ncbi.nlm.nih.gov/24573904
537.Veenboer, P.W., et al. Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphism. Neurourol Urodyn, 2015. 34: 513.
https://pubmed.ncbi.nlm.nih.gov/24706504
538.Przydacz, M., et al. Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury. Int Urol Nephrol, 2018. 50: 1005.
https://pubmed.ncbi.nlm.nih.gov/29569211
539.Lewis, J., et al. A framework for transitioning patients from pediatric to adult health settings for patients with neurogenic bladder. Neurourol Urodyn, 2017. 36: 973.